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Chapter 1 
Bovine Sarcocystis species: a review of the literature 
 
 
Partially adapted from: 
Vangeel, L., Houf, K., Geldhof P., Vercruysse, J., Ducatelle, R. and Chiers, K., 2012. Sarco-
cystis. In: Dongyou Liu (Ed.), Molecular detection of human parasitic pathogens. CRC Press 
(Taylor & Francis Group), Boca Raton, pp. 215–223.  
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1.1 History 
Sarcocystis (S.) tissue cysts were described for the first time by F. Miescher in 1843 when 
they were discovered in skeletal tissue of domestic house mice. The cysts, described as "milky 
white threads", were suspected to have a parasitic origin. They were named after Friedrich 
Miescher and were termed "Miescher's Tubules". Once Lankester introduced the genus name 
Sarcocystis (sarx = flesh and kystis = bladder) in 1882, several species were described based 
on the host species. Confusion occurred, since the life cycle was not known yet and validation 
of the identity of the species was not possible. Although, investigators named two species in 
cattle: S. cruzi (Hasselmann, 1926) and S. hirsuta (Moulé, 1888), any sarcocyst in cattle was 
considered as one species, i.e. S. fusiformis (Dubey et al., 1989a). 
In 1972, pioneering research of Rommel and Heydorn (1972) revealed the two host (hetero-
xenous) life cycle of Sarcocystis. Heydorn et al. (1975) also showed that both intermediate 
and definitive host can be infected by more than one species. Moreover, they were the first 
providing conclusive evidence of the existence of three structurally different Sarcocystis spe-
cies in cattle, with dogs, cats and man as definitive host. Since the original descriptions were 
inadequate and it was impossible to confirm that the originally named species were identical 
to those wherein the life cycle was named, Heydorn et al. (1975) proposed new names (Table 
1.1) combining the name of the intermediate and definitive hosts i.e. S. bovicanis, S. bovifelis 
and S. bovihominis with dogs, cats and man as definitive hosts, respectively.  Nevertheless, 
Levine (1977) stated that the old names S. cruzi (Hasselmann 1926), S. hirsuta (Moulé, 1888) 
and S. hominis, first described by Railliet and Lucet in 1891 (Dubey, 1976), were valid fol-
lowing the international code of zoological nomenclature. These two opposite views also 
caused considerable confusion. Currently, S. cruzi (dog), S. hirsuta (cat) and S. hominis (man) 
are the only valid names according to the international code of zoological nomenclature 
(Dubey et al., 1989a). 
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 Table 1.1: important Sarcocystis species in livestock 
 
Sarcocystis species 
Synonym 
(Heydorn et al., 1975) 
 
Intermediate host 
 
Definitive host 
S. hominis S. bovihominis cattle primates 
S. hirsuta S.bovifelis cattle felids 
S. cruzi S. bovicanis cattle canids 
S. fusiformis - water buffalo cat 
S. suihominis - pig primates 
S. porcifelis - pig felids 
S. miescheriana S. suicanis pig canids 
S. tenella S. ovicanis sheep dog, fox, coyote 
S. gigantea S. ovifelis sheep cat 
S. medusiformis - sheep cat 
S. arieticanis - sheep dog 
S. capracanis - goat dog, fox, wolf 
S. hircicanis - goat dog 
S. moulei S. caprafelis goat cat 
 
1.2 Taxonomy 
Sarcocystis, a genus of tissue cyst-forming coccidia, belongs to the family Sarcocystidae, phy-
lum of Apicomplexa (also known as Sporozoa) and subkingdom of Protozoa (Levine, 1986). 
Related genera include Besnoitia, Cystoisospora, Frenkelia, Hammondia, Neospora and  
Toxoplasma. It has been suggested by different authors that Sarcocystis and Frenkelia belong 
to the same genus (Odening, 1998, Tenter et al., 2002). Frenkel and Smith (2003) suggest 
however to keep the generic distinction. 
Sarcocystis is the largest genus within this family. Over 200 species have been characterized 
(Frenkel and Smith, 2003), and more continue to be described, making Sarcocystis an ubiqui-
tous parasite of mammals (especially sheep, pigs, and cattle), reptiles, and birds (see Table 
1.1).  
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Much of the confusion concerning the taxonomy of Sarcocystis species is due to misinterpre-
tations of original descriptions and inadequate new descriptions (Tenter, 1995). In the late 
1980’s, isoenzyme analysis was used to examine the relatedness of a range of pathogenic and 
non-pathogenic Sarcocystis species from sheep, goats, cattle and mice (O'Donoghue et al., 
1986). However, this method based on the detection of differences in the electrophoretic mo-
bility has not been developed further.  Few years later, molecular techniques have been ap-
plied to examine the phylogenetic relationships of Sarcocystis species to each other, and to 
other cyst-forming coccidians, such as Toxoplasma gondii and Neospora caninum (Johnson et 
al., 1988; Tenter et al., 1992; Ellis et al., 1995). Genomic analysis is beginning to provide 
more insight and new taxonomic schemes are proposed (Tenter et al., 2002). However, rela-
tively few species have been studied in detail and for now, most descriptions are still based on 
the morphology (Frenkel and Smith, 2003). 
 
1.3 Life cycle of bovine Sarcocystis species 
The Sarcocystis species that are described in Bos taurus, namely S. cruzi, S. hirsuta and S. 
hominis, require a heteroxenous (obligatory two-host) life cycle (Figure 1.1), alternating be-
tween hosts that serve as each other’s predator and prey (definitive – intermediate host) 
(Dubey, 1976). The asexual stages of S. cruzi, S. hirsuta and S. hominis with establishment of 
tissue cysts (sarcocysts) occur in domestic cattle, the intermediate hosts. The sexual stages, 
with formation of oocysts, take place in carnivorous definitive hosts, which are canids (dogs, 
coyotes, wolves, and foxes), felids, and primates (humans, rhesus monkeys, baboons and pos-
sibly chimpanzees) for S. cruzi, S. hirsuta and S. hominis, respectively (Heydorn et al., 1975;  
Dubey, 1976; Dubey, 1983b). 
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Figure 1.1: schematic presentation of the life cycle of S. cruzi, S. hirsuta and S. hominis. (Adapted 
from Vangeel et al., 2012)  
The asexual stages with establishment of tissue cysts (sarcocysts) occur in cattle, the intermediate host. 
The sexual stages, with formation of oocysts, take place in the definitive hosts, which are canids, felids 
and primates. 
 
1.3.1  In the definitive host (canids, felids, primates) 
The definitive host gets infected by ingesting raw or undercooked bovine meat, containing 
mature sarcocysts. After ingestion, the sarcocyst wall is mechanically disrupted or digested in 
the stomach and intestine and the enclosed bradyzoites are liberated (Dubey and Lindsay, 
2006). They penetrate goblet cells on the surface lining of the small intestine. Each intracellu-
lar bradyzoite develops in a male or female stage (micro- and macrogamonts) moving into the 
lamina propria.  Fusion of a macrogamont and a microgamont results in a zygote which de-
velops into an oocyst. Spherical oocysts pass into the intestinal lumen and contain two sporo-
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cysts, each with four sporozoites and a granular residual body (Isospora type of oocyst). As 
the oocyst wall is very thin, oval sporocysts are frequently liberated before excretion and in-
dividual sporocysts are excreted with the faeces. The sporocysts are immediately infective 
after being shed in the environment. This is a specific characteristic of the genus Sarcocystis, 
because other members of the family Sarcocystidae shed unsporulated oocysts (Mehlhorn and 
Heydorn, 1978). The shedding is usually low and intermittent, but can sometimes occur in 
large numbers (Mehlhorn and Heydorn, 1978; Heckeroth and Tenter, 2007).  Literature on the 
number of sporocysts excreted by definitive hosts is however scarce. Fayer (1977) and Latif et 
al. (1999) reported shedding of more than 2 million sporocysts a day by infected dogs. Dubey 
et al. (1989a) and Pena et al. (2001) showed however, that the number of sporocysts excreted 
by cats and humans is low in contrast to dogs. During an experimental infection of six persons 
with 200 g raw meat a mean sporocyst count between 1.2 and 23.5 sporocyst per gram faeces 
was reported (Pena et al., 2001). The prepatent period (the interval between infection by a 
parasitic organism and the first diagnostic stage of the organism detectable in that host) of S. 
hirsuta is 7-9 days and for S. cruzi and S. hominis it is 9-10 days. The patent period (the pe-
riod of time in the course of a parasitic disease during which the parasitic organisms can be 
detected in the body) for bovine Sarcocystis species is more than six weeks (Mehlhorn and 
Heydorn, 1978).  
1.3.2 In the intermediate host (cattle) 
The bovine host becomes infected by ingestion of sporocysts in faecal contaminated feed 
and/or water. In the small intestine the sporocyst wall ruptures, releasing the sporozoites 
(Dubey and Lindsay, 2006). They enter the intestinal wall and migrate to the endothelial   
lining of arteries, particularly those of the intestines and mesenteric lymph nodes. The sporo-
zoites multiply in close association with the endothelium, resulting in first-generation 
schizonts containing merozoites (S. hirsuta 7 - 23 days post infection (DPI); S. cruzi 7 - 26 
DPI; S. hominis unknown) (Dubey, 1982a, b, c; Dubey et al., 1988). The schizogony in Sar-
cocystis species happens by endopolygeny (a process of asexual reproduction, in which many 
daughter cells are produced inside a mother cell). Merozoites released from the schizonts en-
ter the bloodstream and develop into second-generation schizonts (S. hirsuta 15 - 23 DPI; S. 
cruzi 19 - 46 DPI; S. hominis unknown) in the endothelium of capillaries of virtually every 
organ, predominantly in renal glomeruli (Dubey, 1982b, c; Dubey and Fayer, 1983; Mehl-
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horn, 1988; Dubey et al., 1988). However those of S. hirsuta are restricted to endothelium of 
capillaries in muscles (Dubey, 1982c). Both first- and second-generation schizonts are located 
within the host cytoplasm and not surrounded by a parasitophorous vacuole (PV). Merozoites 
emerge from the schizonts and circulate extracellularly or may enter mononuclear cells, where 
they divide (Dubey and Fayer, 1983). Division in blood cells has not been seen for S. hirsuta 
(Dubey et al., 1989a). Merozoites from the terminal schizont generation, leave the blood 
stream and invade muscle cells (skeletal or cardiac) (Dubey et al., 1989a) or occasionally neu-
ral tissue (S. cruzi) (Heydorn et al., 1975). Merozoites entering muscle cells round up to form 
metrocytes and initiate sarcocyst formation. A wall develops around the metrocytes, forming 
an immature sarcocyst. Consequently the sarcocyst is always located within a PV in the host 
cell. Multiplication by endodyogeny (a process of asexual reproduction, in which two daugh-
ter cells are produced inside a mother cell) in the tissue cyst leads to the accumulation of nu-
merous metrocytes (globular mother cells) and the sarcocyst increases in size. In the centre of 
the cyst, the small, rounded, non-infectious metrocytes differentiate in crescent- or banana-
shaped bodies, called bradyzoites, which are infective for the definitive host. Bradyzoites 
measure from 3-5 µm up to 18 µm depending on the species. A cyst is mature when it con-
tains more bradyzoites than metrocytes (Mehlhorn and Heydorn, 1978). Maturation varies for 
each species and takes approximately 62 - 98 days for S. cruzi and S. hominis; however, for 
macrocyst-forming species as S. hirsuta, it can be up to 1 – 4 years (Heydorn et al., 1975; 
Rommel et al., 1995). Mature sarcocysts of each species differ in size (from 0.1 mm to 30 
mm) and shape. Some always remain microscopic, whereas others (can) become macroscopi-
cally visible (e.g. S. hirsuta) (Dubey et al., 1990). Whether S. hominis produces macroscopic 
cysts has not been determined (Böttner et al., 1987; Dubey et al., 1988). Sarcocysts can persist 
for months or years in the intermediate host. In old cysts, bradyzoites that are located centrally 
degenerate and are replaced by a hollow (Dubey et al., 1989a).  
Sarcocysts develop distinct cyst walls that vary in thickness and organization of the villar pro-
trusions (Dubey et al., 1989a; Odening et al., 1995) (described in detail in 1.4.1.1 “Morpho-
logical techniques”). Internally the sarcocyst is compartmented by septae, which is a specific 
characteristic of Sarcocystis species (Mehlhorn and Heydorn, 1978). 
 
Although ingestion of sporocysts is the major mode of transmission for cattle, vertical trans-
mission of S. cruzi has been documented in experimental studies (Savini et al., 1996a) and 
sporadically in natural infections (Dubey and Bergeron, 1982; Hong et al., 1982), though 
rarely (Moré et al., 2009).  
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To date, the possibility of transmission through blood is not shown in natural infections, but 
Fayer and Leek (1979) have described that Sarcocystis can be successfully transmitted be-
tween intermediate hosts by transfusion of blood, containing merozoites.  
Since lactogenic transmission was described for Toxoplasma gondii, transmission via milk or 
colostrum was also tested experimentally for S. cruzi, but evidence was not found (Fayer et 
al., 1982).  
1.4 Detection and identification  
1.4.1 In the intermediate host 
A variety of techniques have been used to investigate Sarcocystis species in muscles of bo-
vines. Each method has its advantages and disadvantages.  
1.4.1.1 Morphological techniques (Gross – Light microscopy - TEM) 
Gross inspection of muscle tissue is only possible for macrocyst-forming species (Böttner et 
al., 1987; Dubey et al., 1990) and this technique is therefore not sensitive enough to be a reli-
able detection method (Table 1.2).  
Sarcocysts can be detected in unstained fresh squash preparations by trichinoscopy or stere-
oscopy at magnification of 10-60X (Gut, 1982). Although these techniques are not suitable 
for identification, relatively more tissue can be examined in contrast to histological examina-
tion; hence it is more sensitive. However, sarcocysts may be easily overlooked by untrained 
observers (van Knapen et al., 1987; O’Donoghue and Rommel, 1992). If infection levels are 
high and tissue cysts are > 500 µm, isolation can be performed by dissecting muscle samples 
using a stereomicroscope and recovering the cysts with dissecting needles (Yang et al., 2001). 
Intact tissue cysts can also be recovered using a sedimentation technique. The detection and 
isolation can then be done by stereomicroscopical examination of the sediment (Markus, 
1979).  
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Histological examination is frequently used, but is not a sensitive detection method due to 
the small amount of sampled tissue (Collins et al., 1980). On the other hand, histology permits 
to study the sarcocyst morphology. Routine species identification is based on morphological 
examination of the cyst wall (Table 1.2). However, due to the low resolution by light micro-
scopic examination, it is only possible to differentiate between thin- and thick-walled species 
(Figure 1.2).  S. cruzi is a thin-walled species (<1 µm) (Figure 1.2 A) which can easily be dis-
tinguished from S. hominis and S. hirsuta, both thick-walled sarcocysts (Figure 1.2 B). Their 
walls are radially striated and 2.5 - 9.0 μm thick (Dubey et al., 1989a). Distinguishing S. 
hominis from S. hirsuta is unreliable by light microscopy (Odening et al., 1995).  
 
 A  B 
Figure 1.2: A: a thin-walled species (<1 µm) S. cruzi. B: a thick-walled sarcocyst is shown (S. 
hominis or S. hirsuta). HE staining, 400x. 
 
Immunohistochemical methods have been developed in order to improve the sensitivity and 
specificity of histological detection of life cycle stages of Sarcocystis species in the interme-
diate hosts, especially in sheep and horses (Uggla and Buxton, 1990). However, these me-
thods are complicated by the fact that polyclonal antisera show high cross-reactivity with an-
tigens of heterologous species. Moreover, sera of rabbits immunized with Sarcocystis antigens 
Table 1.2: Cyst characteristics based on gross, light microscopic and TEM examination 
Sarcocystis species Gross Light microscopy TEM 
S. cruzi microscopic thin-walled hair-like protrusions 
S. hirsuta micro-/macroscopic thick-walled finger-like protrusions 
S. hominis microscopic thick-walled bulb-shaped protrusions 
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may also cross-react with antigens of other cyst-forming coccidians (Uggla and Buxton, 
1990). Therefore, a species-specific diagnosis can be made only when specific monoclonal 
antibodies are used. These have been developed only for S. cruzi (Burgess et al., 1988) in cat-
tle, but are not commercially available. In this report, Burgess et al. (1988) identified one 
monoclonal antibody that reacted with antigens of merozoites as well as bradyzoites and 
sporozoites of S. cruzi. 
 
The most reliable method for morphology-based species identification is transmission elec-
tron microscopy (TEM) (Dubey et al., 1989b; Odening et al., 1995) (Table 1.2). The cyst wall 
of S. hominis (Figure 1.3A) is characterized by finger-like villar protrusions that are broadly 
seated on the cyst surface, containing long microfilaments in the core, that run from the base 
to the tip. S. hirsuta (Figure 1.3B) however, is characterized by diagonally bent, bulb-shaped, 
or club-shaped villar protrusions arising with a stalklet from the cyst wall and containing large 
osmiophilic granules (Dubey et al., 1989b; Odening et al., 1995). 
Although routine identification is based on cyst wall morphology, a lot of controversy still 
exists on the reliability (Tenter, 1995). Since, morphological characters, such as cyst size and 
cyst wall structure may vary during cyst development, location or due to fixation (Dubey, 
1989a). As there is no reliable way to determine the age of sarcocysts in naturally infected 
cattle, caution should be taken with the taxonomic value and with respect to describing a new 
species only based on the cyst morphology (Böttner et al., 1987; Tenter, 1995).  
 
A B 
Figure 1.3: schematic representation of the cyst wall morphology of both thick-walled species.  
A:  S. hominis. B: S. hirsuta. 
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1.4.1.2 Digestion techniques 
Peptic (Seneviratna et al., 1975) or tryptic (Boch et al., 1978) digestion techniques, with con-
sequent microscopical examination, are frequently used, practical and sensitive methods for 
Sarcocystis detection (Boch et al., 1978; Collins et al., 1980; van Knapen et al., 1987). How-
ever, sarcocyst identification is not possible, because these methods result in lysis of not only 
muscle tissue but also of the sarcocyst walls, releasing the bradyzoites. The latter survive in 
the incubation fluid and can be examined at 400X magnification, metrocytes are however not 
resistant to digestion (Dubey et al., 1989a). 
These methods are used in epidemiological studies, but they can also be used for purification 
of bradyzoites for antigen and nucleic acid preparations. To purify the bradyzoites, a subse-
quent step of density gradient centrifugation is needed. The density of Sarcocystis bradyzoites 
varies with the age of the tissue cyst and with the species, therefore optimizing the composi-
tion of the discontinuous density gradients is always needed (Heckeroth and Tenter, 2007). 
1.4.1.3 Serology 
Several serological tests based on crude antigen preparations have been developed and ap-
plied for the diagnosis of Sarcocystis infection in different intermediate host species (Tadros 
et al., 1980; Uggla and Buxton, 1990). In cattle, an indirect haemagglutination test (IHA) 
(Lunde and Fayer, 1977) and an enzyme-linked immunosorbent assay (ELISA) (Tadros et al., 
1979; Savini et al., 1997) have been applied for serodiagnosis of sarcocystosis.  
The usefulness of serological tests for the diagnosis of Sarcocystis infections has been limited 
however, by the high antigenic cross-reactivity among different Sarcocystis species. In addi-
tion, the Sarcocystis stages from which traditionally antigens have been derived are intracellu-
lar and therefore the antigen preparations lack standardization and are frequently contami-
nated with debris of host tissue (Tenter, 1995). 
At present no serological assay for the demonstration of bovine Sarcocystis antibodies is 
commercially available.  
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1.4.1.4 Molecular techniques 
To date, there are some molecular based methods that have been developed, though primarily 
in a research-based context.  
Tests targeting rRNA, for example, ribosomal hybridization assay (Gajadhar et al., 1992), 
have been developed for some Sarcocystis species. These methods have been suggested to be 
more sensitive and accurate than assays targeting the rRNA genes, as there is up to 50 times 
more RNA than DNA in a cell, of which 90-95% is rRNA (Zarlenga and Higgings, 2001). 
Since RNA is not stable and easily degraded by enzymatic digestion, these assays are not 
suitable for the diagnosis of clinical or epidemiological samples (Heckeroth and Tenter, 
2007). Moreover, standardization of RNA hybridization assays is difficult (MacPherson and 
Gajadhar, 1993) and the necessity of using radioactively labeled oligonucleotide probes re-
stricts the use to specialized laboratories (Heckeroth and Tenter, 1999).  
Since the development of the Randomly Amplified Polymorphic DNA Polymerase Chain 
Reaction (RAPD-PCR) fingerprinting technology, this method has been used in intermediate 
hosts to distinguish different Sarcocystis species (Macpherson and Gajadhar, 1994; Güçlü et 
al., 2004). An advantage of this technique is that short regions of genomic DNA can be ampli-
fied without prior knowledge of gene sequences. DNA sequence analysis of these PCR pro-
ducts can then be used to design species specific primers. However, this method has not been 
developed as a diagnostic test. The reason is that RAPD is laden by technical drawbacks, 
through which standardization of the assay between laboratories is difficult (Zarlenga and 
Higgings, 2001).   
In recent years the small subunit rRNA gene has been used extensively to differentiate be-
tween apicomplexans and other eukaryotic species. Due to its abundance in the genome, the 
sensitivity of the tests increases. Moreover, its double feature of hypervariable regions 
interspearsed within highly conserved DNA sequences makes it a useful target for developing 
molecular-based diagnostics (Neefs et al., 1991; Tenter and Johnson, 1997; Fischer and 
Odening, 1998; Prichard and Tait, 2001). The rapidly growing database of 18S rDNA gene-
rated by phylogenetic studies of Sarcocystis species provides a rich source of sequences that 
can be exploited to develop specific PCRs (Fischer and Odening, 1998).  
In the last decade, a number of PCR-based techniques (e.g., genus or species specific PCR, 
nested PCR, PCR-RFLP) have been established, especially for the identification of tissue 
cysts in livestock. They have been used however mostly in taxonomic studies (Tenter et al., 
1994; Heckeroth and Tenter, 1999; Holmdahl et al., 1999; Yang et al., 2002; Li et al., 2002).  
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1.4.2 In the definitive host  
1.4.2.1 Faecal examination 
Diagnosis of intestinal sarcocystosis requires identification of sporocysts in the stool. Sporo-
cysts can be observed by bright-field microscopy in a faecal flotation wet mount just beneath 
the coverslip. As an alternative, the traditional flotation technique based on concentration 
methods (specific gravity 1.15 or more) with satured sodium chloride (NaCl), sucrose or zinc 
sulphate (ZnSO4) solutions can be used (Dubey et al., 1989a). The concentration step is ne-
cessary, because the number of sporocysts in the faeces is often low. The latter technique is 
more commonly used than the former. The determination of numbers of oocysts/sporocysts 
can be done by the McMaster technique (Heckeroth and Tenter, 2007). In addition, a modified 
Kato thick smear technique, commonly used for the diagnosis of helminthiasis, has also been 
tested successfully for the diagnosis of Sarcocystis sporocysts (Tungtrongchitr et al., 2007). 
Morphological species identification/differentiation is not possible for the oocyst/sporocyst 
stages of this parasite. Sporulated oocysts are spherical, generally colorless, thin-walled (<1 
µm) and contain two elongated sporocysts. The colorless wall is delicate and often ruptures. 
An oocyst residuum and micropyle are absent. Similarly, the morphology of sporocysts has no 
taxonomic value. Except for minor variations in size, the structure is the same (Mehlhorn and 
Heydorn, 1978). Each sporocyst contains four elongated sporozoites and a compact or dis-
persed granular residual body, but a Stieda body is absent. Because sporozoites are curved in 
the sporocyst, all four are often not seen in a single plane of focus. Each sporozoite has a cen-
tral to terminal nucleus and several cytoplasmic granules, but there is no refractile body. The 
approximate size of the sporocyst (Figure 1.4) is 9 x 15 µm for S. hominis, 11-14 by 7-9 µm 
for S. hirsuta, and 14.5 – 17 by 9 – 11 µm for S. cruzi (Fayer, 1974; Heydorn et al., 1975; 
Dubey, 1976; Mehlhorn and Heydorn, 1978). 
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Figure 1.4: Sarcocystis spp. sporocyst, 100 x objective. A: thin cyst wall. B: sporozoite. C: residual 
body. (Source: http://people.upei.ca/sgreenwood/html/protozoa.html) 
 
1.4.2.2 Serology 
An indirect fluorescent antibody test (IFAT) is described to detect circulating antibodies 
against S. hominis in sera in man (Tadros et al., 1974). However, Heckeroth and Tenter 
(2007) assumed that data on Sarcocystis infections in definitive hosts have been complicated 
by the fact that these hosts do not develop parasite – specific antibodies.  
 
1.4.2.3 Molecular techniques 
Although DNA templates are stable targets for PCR amplification and diagnostic samples can 
be stored at ambient temperature for some time, each of the range of different sources of para-
site material (faeces, tissue) involves different problems for PCR-based diagnosis, associated 
with inhibitors and sensitivity (Tenter et al., 1994). Therefore PCR assays that have been 
shown to be specific and sensitive on tissue in livestock probably cannot be used as such for 
the diagnosis of Sarcocystis species in faecal samples. 
Recently, for intestinal sarcocystosis Xiang et al. (2009) have evaluated a genetic approach 
for the detection and identification of S. hominis sporocysts based on a seminested PCR-
RFLP assay described by Yang et al. (2002). This method is based on the amplification of a 
fragment from the18S rRNA gene, using a semi-nested PCR combined with RFLP. Due to the 
low number of sporocysts excreted by the definitive host, Xiang et al. (2009) consider that 
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semi-nested PCR is necessary to increase the sensitivity of the assay. The sensitivity of this 
test was not established yet but this assay showed to be useful as a noninvasive diagnostic 
technique for human intestinal sarcocystosis. The primers described for this assay target rela-
tively conserved portions of 18S rDNA. Therefore, successful amplification indicates only the 
presence of a Sarcocystis species. When used in conjunction with RFLP or sequencing, how-
ever, species identification is possible (Yang et al., 2002).  
1.5 Pathogenicity 
Little is known about the mechanisms of Sarcocystis species that cause pathogenicity in the 
intermediate as well as in the definitive hosts (Dubey et al., 1989a).  
1.5.1 In the intermediate host 
In cattle, infection can result in acute disease during the early phase of infection and chronic 
disease during the late phase of infection. The severity of clinical symptoms is related to the 
number of ingested sporocysts. There are no clinical symptoms that are pathognomonic for 
sarcocystosis (Tenter, 1995).  
In general, species transmitted by canids are the most pathogenic for the intermediate host. 
Experimental infection studies with S. cruzi (infection dose ranging from 0 – 500 x 106 sporo-
cysts) showed that an intake of less than 1000 sporocysts causes no clinical signs. Ingestion of 
a large dose (50.000 or more) results in clinical symptoms three to four weeks after infection 
(Dubey et al., 1982). It can cause fever, anorexia, anaemia, weight loss, hair loss, weakness, 
muscle twitching, prostration, abortion, reduced milk yield, hypersalivation, neurologic signs 
and death. Fever is usually associated with parasitaemia and clinical signs are generally seen 
during the second schizogonic cycle in blood vessels (Dubey and Lindsay, 2006). The other 
two bovine Sarcocystis species, S. hirsuta and S. hominis are only mildly pathogenic for cattle 
(Dubey, 1983a; Dubey et al., 1988). Experimental infection trials of these species were per-
formed with a sporocyst infection dose ranging between 5000 – 25 x 106 for S. hirsuta and 
105 - 106 sporocysts for S. hominis. Infection with 100.000 S. hirsuta sporocysts caused clini-
cal symptoms including fever, diarrhoea and mild anaemia. Death was however, not described 
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(Dubey, 1983a). Inoculation of 1 million sporocysts of S. hominis caused only mild anaemia 
(Dubey et al., 1988).  
Few field cases of acute sarcocystosis have been diagnosed however, in animals exposed to 
natural levels of infection. The first natural outbreak of acute sarcocystosis was reported in 
1961 and was named Dalmeny disease, after the Canadian town where the outbreak occurred 
(Corner et al., 1963).  Subsequently, cases have been reported in Canada (Meads, 1976), Eng-
land (Clegg et al., 1978), Ireland (Collery and Weavers, 1981), Norway, Australia and the US.  
Cattle surviving the acute disease syndrome recover slowly although most succumb to chronic 
sarcocystosis, showing weight loss, hypersalivation, hyperexcitability and hair loss (especially 
on the neck, rump and tail switch). Data about the percentage of animals that develop chronic 
disease are not available. Some months after infection, animals can develop CNS symptoms 
(nystagmus, opisthotonus and lateral recumbancy with running gate) (Fayer and Dubey, 
1986).  
Chronic sarcocystosis can also result from the ingestion of a low dose of a pathogenic species 
and is more common than acute disease (Dubey et al., 1989a). It can cause reduced milk pro-
duction, body weight, body weight gain (Frelier, 1977; Fayer and Dubey, 1986; Daugschies et 
al., 2000) and quality of meat (Fayer and Elsasser, 1991). It has been assumed that muscle 
metabolism is affected in these cattle (Telles de Jesus Filho and Miraglia, 1977; Daugschies et 
al., 2000).  
1.5.2 In the definitive host 
Infection in canids and felids does not cause any clinical symptoms (Dubey et al., 1989a). In 
man, the severity of the symptoms is correlated with the number of ingested sarcocysts 
(Fayer, 2004). The clinical course after infection with S. hominis in humans is usually mild 
and in many cases even asymptomatic (Fayer, 2004). It is characterized by transient nonspe-
cific gastro-intestinal complaints, like nausea, stomach ache, abdominal pain and distension, 
and (watery) diarrhoea (Pena et al., 2001; Fayer, 2004). The symptoms appear 3 - 6 hours 
after eating infected beef and last about 36 hours (Fayer, 2004). In some cases abdominal dis-
comfort, vomiting, diarrhoea, dizziness, fatigue, anaemia, and segmental necrotizing enteritis 
has been reported (Bunyaratvej and Unpunyo, 1992; Xiang et al., 2009).  
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1.6 Immunity 
Cellular and humoral immune responses in infected animals indicate that Sarcocystis spp. are 
immunogenic in intermediate hosts (Dubey et al., 1989a). Due to the lack of schizogony in 
the definitive host, they acquire little or no immunity, and each meal of infected meat can 
thus initiate a new round of sporocyst production (Dubey and Lindsey, 2006). 
 
In cattle (intermediate host), the major components of the humoral response are IgM and 
IgG1. The IgM response appears early, but is transient. Experimental studies show that the 
IgM response begins to develop three to four weeks after infection and declines to low levels 
(near preinfection level) in two to three months, which is the time the sarcocysts mature. 
Three to five weeks post infection IgG1 antibodies arise. A peak concentration is seen during 
the early sarcocyst formation and persists during the chronic infection for at least five to six 
months (Lunde and Fayer, 1977; Fayer and Prasse, 1981; Gasbarre et al., 1984).  
Cattle surviving a primary Sarcocystis infection usually develop a transient immunity that 
protects them against acute disease after challenge with the homologous species, but not after 
infection with a pathogenic heterologous species (Uggla and Buxton, 1990; O’Donoghue and 
Rommel, 1992). The protection against acute disease appears to be maintained by continuous 
low dose infections or possibly intermittent exposure. Nevertheless, the mechanisms of pro-
tection are not yet understood (O’Donoghue and Rommel, 1992). 
The predominant cells infiltrating visceral and muscular tissue are lymphocytes and macro-
phages (Johnson et al., 1975; Dubey et al., 1982). Sarcocysts present in muscle cells of natu-
rally infected cattle however, are usually not accompanied by an inflammatory response 
(Dubey et al., 1989a).  
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1.7 Prevalence 
1.7.1 In the intermediate host 
Sarcocystis infection is common in many animals worldwide. In cattle the prevalence of Sar-
cocystis in adult bovine muscle is close to 100% (Table 1.3) in most regions of the world 
where it has been studied (Böttner et al., 1987; van Knapen et al., 1987; Vercruysse et al., 
1989; Fortier et al., 1993; Woldemeskel en Gebreab, 1996; Latif et al., 1999; De Bosschere en 
Ducatelle, 2001; Pena et al., 2001).  
Infections with more than one species are very common (78.2%) (Böttner et al., 1987). Never-
theless, little is known in mixed infections about the proportion of each species in cattle, due 
to difficulties in correct identification (Odening et al., 1995). Most surveys indicate that S. 
cruzi is the most prevalent species (Böttner et al., 1987; Dubey et al., 1989a; Fortier et al., 
1993). Data about the prevalence of S. hominis show discrepancy between the surveys, though 
care should be taken in comparing those studies since they were based on different morpho-
logical methods. In two studies based on TEM examination in Brazil (Pena et al., 2001) and 
France (Solomon, 1991), S. hominis was detected in 94 and 57% of the samples, respectively. 
In other studies carried out in India (Jain and Shah, 1987) and Germany (Boch et al., 1978) 
with light microscopic identification, S. hominis prevalences were 12.2 and 63%, respectively. 
The reliability of the latter studies is questionable, since Odening et al. (1995) stated that light 
microscopic examination is unreliable to distinguish S. hominis from S. hirsuta.  
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Table 1.3: Prevalence of bovine associated Sarcocystis species in cattle. 
Country Tech-
nique 
Thin-
walled 
(%) 
Thick- 
walled 
(%) 
Overall 
prevalence 
(%) 
Reference 
Germany b, c 65.5 63 hominis 
35 hirsuta 
99.7 Boch et al., 1978 
New Zealand a, e 98 79.8 100 Böttner et al., 1987 
India d 78.1 12.2 80.3 Jain and Shah, 1987 
Netherlands b, c - - 100 van Knapen et al., 1987 
Belgium a, e 97 56 97 Vercruysse et al., 1989 
France e, f 70.7 57 hominis 
24 hirsuta 
90 Solomon, 1991 
France (Calvados) e 75.4 4.6 80 Fortier et al., 1993 
Ethiopia e - - 82 Woldemeskel and Ge-
breab, 1996 
Iraq a - - 93.3 Latif et al., 1999 
Belgium a - - 100 De Bosschere and 
Ducatelle, 2001 
Brazil e, f 92 94 hominis 
70 hirsuta 
100 Pena et al., 2001 
Iran  e 89 21 100 Nourani et al., 2010 
Southern Italy e - - 96 Bucca et al., 2011 
a pepsin/HCl digestion, b tryptic digestion, c trichinoscopy, d compound microscope, e light microscopy, f TEM  
1.7.2 In the definitive host 
Data about prevalence of Sarcocystis species in the definitive hosts differ between the studies; 
moreover these reports do not differentiate the species. Prevalences in dogs range from 0% to 
9% (Haralabidis et al., 1988; Aboshehada and Ziyadeh, 1991; Bugg et al., 1999; Barutzki and 
Schaper, 2003; Sager et al., 2006; Claerebout et al., 2009). In cats, 2.2% showed to be in-
fected (Barutzki and Schaper, 2003). Regarding the prevalence of intestinal sarcocystosis in 
humans, published data on natural infections are limited. In a German study 13.64% of 403 
patients with intestinal complaints were infected with intestinal parasites of whom 2% were 
shedding Sarcocystis sporocysts, but a distinction between S. hominis and S. suihominis was 
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not made (Gauert et al., 1983). In a Thai study 8.0% of 1124 rural residents were infected 
with Sarcocystis species (Tungtrongchitr et al., 2007). 
1.8 Epidemiology 
Although little epidemiological research is performed, a variety of conditions may permit the 
high prevalence of Sarcocystis species.  
The definitive host gets infected by eating raw or undercooked meat, containing mature sar-
cocysts. In some countries, where the frequency of consumption of raw or undercooked meat 
is relatively common, humans should get easily infected (Dubey and Lindsay, 2006). At a 
temperature of 2-4°C bovine sarcocysts remain infective in meat for three weeks (Stephan et 
al., 1998). This implies that sarcocysts remain longer infective than the shelf life of raw meat. 
Although data are not available for S. hominis, Saleque et al. (1990) reported that sarcocysts 
of S. miescheriana in pork became non-infective after heating at 60°C for 20 min, at 70°C for 
15 min or at 100°C for 5 min or after freezing for two days at -4°C or one day at -20°C.   
Generally, as stated above, shedding of sporocysts by the definitive host can last for weeks or 
sometimes several months and numbers of excreted cysts can vary (Mehlhorn and Heydorn, 
1978). The fact that Sarcocystis oocysts, unlike those of many other species of coccidia, are 
passed in faeces in the infective form, frees them from dependence on weather conditions for 
maturation and infectivity (Dubey, 1976). Sporocysts can survive in faeces of the definitive 
host for 2 years. Low temperatures or freezing does not influence their infectivity. However, 
in vitro investigations showed that sporocysts are sensitive to dryness, direct sunlight and 
strong fluctuations in temperature (Heydorn, 1980; Savini et al., 1996b).  The sensitivity to 
dryness was also put forward as a possible explanation by Savini et al. in 1992 when they 
found that the prevalence of Sarcocystis was lower in cattle originating from arid and semi-
arid regions in contrast to those from tropical and temperate regions.  
 
Transmission of sporocysts can be direct or indirect.  
Direct transmission is caused by contamination of feed and/or pasture of cattle with faecal 
material from the definitive hosts. The density of the intermediate host could influence the 
prevalence, since Savini et al. (1992) attributed the overall lower prevalence (52%) in Wes-
tern Australia, in contrast to other countries, to the extensive manner of animal husbandry, 
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which results in less frequent contact between the intermediate and definitive host. Consider-
ing the bovine age, Savini et al. (1992) showed that only few animals younger than one year 
were infected in Western Australia, attributing this to a low contact in the suckling period 
with sporocysts. The infection rate has been shown to be higher in older cattle, up to four 
years, after which the prevalence decreases again (Savini et al., 1992).  
Indirect spreading may occur via flooding or irrigation of pastures with water from sewage 
treatment plants. Furthermore, the contribution of agricultural use of sewage sludge has been 
considered as important, but has not been documented decisively (Burger and Wilkens, 1986). 
Finally, synanthropic flies, particularly the common house fly (Musca domestica) and cock-
roaches (order Blattaria or Blattodea) have been suggested as vectors of Sarcocystis (Markus, 
1980). The transmission by synanthropic insects is predominantly via mechanical dislodge-
ment from the exoskeleton, faecal deposition and regurgitation (Graczyk et al., 2005).  
1.9 Economical impact  
Not only acute sarcocystosis, but also chronic sarcocystosis can cause economic losses in 
livestock industry due to reduced milk production, body weight, body weight gain (Frelier, 
1977; Fayer and Dubey, 1986; Daugschies et al., 2000) and quality of meat (Fayer and El-
sasser, 1991). However, losses are difficult to calculate, because up to 100% of the cattle are 
infected and clinical disease is difficult to diagnose. Besides this, additional losses are caused 
by S. hirsuta which can cause macroscopic cysts in muscle tissue resulting in condemnation at 
slaughter (Dubey et al., 1990).  
1.10  Prevention, control and treatment 
The only recommendation that can be made in order to control Sarcocystis infections is inter-
rupting the life cycle. Shedding of Sarcocystis sporocysts in faeces of the definitive hosts is 
the key factor in the spread of Sarcocystis infection (Dubey and Lindsay, 2006). Control is 
difficult to impossible, but attempts should be made to prevent animal pasture/stables, water 
and feed to become contaminated by faeces from dogs, foxes, cats, man and other definitive 
hosts.  
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Research on the viability of sporocysts of bovine associated Sarcocystis species is not per-
formed so far, but viability tests for S. neurona showed that heat treatment is the most effec-
tive means of killing. Treatments with bleach (10%, 20%, and 100%), 2% chlorhexidine, 1% 
betadine, 5% o-benzyl-p-chlorophenol, 12.56% phenol, 6% benzyl ammonium chloride, and 
10% formalin were not effective in killing sporocysts. However, treatment with undiluted 
ammonium hydroxide (29.5% ammonia) for 1 hour killed sporocysts (Dubey et al., 2002). 
Dead animals should never be left for carnivores to eat and uncooked meat should never be 
fed to dogs and cats. Meat should be frozen or thoroughly cooked before it is eaten by pets or 
humans (Dubey and Lindsay, 2006).  
There is no vaccine available to protect cattle or the definitive hosts against sarcocystosis 
(Dubey and Lindsay, 2006). Chemoprophylaxis using the anticoccidial drugs amprolium 
showed to be effective in preventing severe illness and death in experimentally infected calves 
(Fayer and Johnson, 1975). Administration of lasalocid, decoquinate and monensin on the 
other hand showed only minimal or no effect in calves (Foreyt, 1986).  
In humans there is no known prophylaxis or therapeutic treatment for intestinal sarcocystosis 
(Fayer, 2004). But on the basis of results in experimental animals, it is plausible that sulfona-
mides and pyrimethamine may be helpful in treating sarcocystosis (Dubey and Lindsay, 
2006).  
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2.1 Introduction 
Bovine Eosinophilic Myositis (BEM) is a histopathological descriptive term referring to a 
myositis in cattle in which the predominant inflammatory cell type is the eosinophilic granu-
locyte. Since cattle do not show any clinical symptoms, this pathological entity typically is 
observed in slaughterhouses and meat cutting plants. 
2.2 Prevalence, legislation and economical impact 
BEM appears worldwide in bovine carcasses and has been described in Europe, the United 
States, Canada, Iran, Korea and Japan (Reiten et al., 1966; Imes and Migaki, 1967; Van Hoof 
et al., 1972; Rimaila-Pärnänen and Nikander, 1980; Jensen et al., 1986; Gajadhar et al., 1987; 
Bundza and Feltmate, 1989; Fortier et al., 1993; Wouda et al., 2006; Do et al., 2008; Kimura, 
2011; Javadi and Doustar, 2011). The prevalence varies according to the region, but recent 
data are missing (Table 2.1). Between 1960 and 1971, 0.003% of the slaughtered cattle in 
Belgium were condemned for BEM (Van Hoof et al., 1972). In the Calvados region of France 
(Fortier et al., 1993) and in Canada (Bradley and Taylor, 1993) a prevalence of 0.002% and 
0.006%, respectively is reported. Regional differences were pronounced in the United States 
of America where the average of condemnations due to BEM is 0.011%, whereas exceptio-
nally high BEM-associated carcass condemnations (up to 5%) have been reported in the wes-
tern part of the USA (Jensen et al., 1986).  
 
Table 2.1: prevalence of BEM in slaughtered carcasses in different countries 
Country Prevalence (%) Reference 
Belgium 0.003% Van Hoof et al., 1972 
France 0.002% Fortier et al., 1993 
Canada 0.006% Bradley & Taylor, 1993 
USA Colorado 0.028% Reiten et al., 1966 
USA 0.011% Jensen et al., 1986 
Western USA 5% Jensen et al., 1986 
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Although BEM is not detectable in vivo, it results in economic losses at slaughter due to car-
cass condemnation as well as meat condemnation in meat cutting plants. Until the end of 
2005, condemnation of BEM carcasses was based on the Royal Decree of March 9th 1953 
(appendix 2, chapter II), in which is mentioned that meat with an abnormal visual aspect, 
whatever the cause, must be condemned. Since January the 1st of 2006, condemnation is based 
on the European Regulation (EC) no. 854/2004 (annex 1, section 2, chapter 5): “meat is to be 
declared unfit for human consumption if it indicates pathophysiological changes”. 
During meat inspection the lesions of BEM are often difficult to diagnose, since they are most 
of the time only visible on the cut surface of muscle tissue (the characteristics of the lesions 
are described below, “Lesions and symptoms”). Hence, they can pass unnoticed through car-
cass inspection (Stephan et al., 1998). This results in a shift of the problem to the level of the 
meat cutting plant, because anomalies are then found on an approved carcass. Data about the 
occurrence of BEM in meat cutting plants are not available, but it can be assumed that it is 
higher than in slaughterhouses.  
2.3 Etiology 
Inflammatory myopathies, to which BEM belongs, are a heterogeneous group of muscle dis-
eases of which the causes described in literature are various. They can be caused by an auto-
immune response, allergic reaction or following environmental exposure to xenobiotics, drugs 
or by infection with bacteria, viruses or parasites (Bruschi and Chiumiento, 2011).  
The etiology of BEM is yet unknown. Neither helminths nor viral or bacterial microorganisms 
have been detected in the lesions (Oghiso et al., 1977; Jensen et al., 1986).  
During investigations of experimental trichinosis in cattle, Smith et al. (1990) found focal 
lesions of eosinophilic myositis post infection. The gross aspect of these experimentally in-
duced lesions was however not comparable with natural cases. Moreover, a survey by Smith 
et al. in 1991 of natural cases, based on ELISA, peptic digestion and histology, showed that 
trichinosis is unlikely to be associated with BEM. Since, larvae of Trichinella were not reco-
vered by pepsin digestion, nor were they observed microscopically and only one animal was 
positive for Trichinella antibodies. 
Besides infectious agents, host dependent factors also have been examined by comparing pro-
tein patterns between normal and BEM animals. Only a small difference in the α-globulin 
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region, which could point to a subtle difference in an enzyme or isoenzyme constitution in 
BEM animals, was reported. Nevertheless, it was not certain if this could be associated with 
the disease (Tengerdy and Imes, 1967).  
Today, scientists believe that Sarcocystis species are associated with the development of this 
pathological entity (Gajadhar and Marquardt, 1992; Wouda et al., 2006).  Following indirect 
indications have been found: 
i. Sarcocystis species are frequently demonstrated in the centre of BEM lesions after 
semiserial histological examination (Jensen et al., 1986; Gajadhar et al., 1987; Gajad-
har and Marquardt, 1992). Species identification of sarcocysts in BEM lesions is con-
fusing as both thin- and thick-walled sarcocysts (Jensen et al., 1986), S. hominis or S. 
hirsuta (Rimaila-Pärnänen and Nikander, 1980),  S. cruzi (Gajadhar and Marquardt, 
1992), S. hominis (Wouda et al., 2006) and even an unidentified species (Gajadhar et 
al., 1987) have been observed. The identification on species level however, was based 
on the morphology of the cyst wall, which is hampered due to the fact that intrale-
sional sarcocysts are mostly damaged (Wouda et al., 2006).  
ii. Saito et al. (1993) showed positive labelling of the necrotic centre in granulomatous 
lesions with an anti-S. cruzi rabbit serum.  
iii. Gajadhar and Marquardt (1992) and Wouda et al. (2006) observed that intralesional 
sarcocysts are damaged and this could evoke an immune response. 
iv. Researchers detected functional Sarcocystis cruzi specific IgE using a passive cuta-
neous anaphylaxis test and local IgE binding in the environment of degenerating sar-
cocysts by immunofluorescence techniques (Granstrom et al., 1990a; Granstrom et al., 
1990b). Ely and Fox (1989) and Granstrom et al. (1989) reported also an increase in 
IgG for S. cruzi in BEM animals. However, it is not clear if an increase of IgG is asso-
ciated with this pathological entity (Ely and Fox, 1989).  
v. It was shown that carcasses with BEM contain less bradyzoites than normal bovine 
carcasses (Gajadhar and Marquardt, 1992; De Bosschere and Ducatelle, 2001), assu-
ming that this was due to a specific immune response towards the sarcocysts.  
Nonetheless, due to the high prevalence of Sarcocystis in cattle, and the low prevalence of 
BEM, the presence of sarcocysts inside lesions could be a coincidence (Van Hoof et al., 
1972). Experimental oral infection with Sarcocystis moreover, did not lead to BEM (Dubey et 
al., 1982; Dubey, 1983; Dubey et al., 1988).   
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2.4 Pathogenesis 
Since in vivo diagnosis is not possible and experimental models are not available yet, research 
on the pathogenesis of BEM is hampered. Several hypotheses have however been put forward 
in the past.  
First of all, Granstrom et al. (1989) hypothesized that BEM animals would be genetically pre-
disposed to produce IgE in response to Sarcocystis bradyzoite antigens, and that BEM would 
be an abnormal response to sarcocyst degeneration.  
Secondly, Jensen et al. (1986) hypothesized, based on the morphological characteristics of the 
lesions, that both type I and type IV hypersensitivity are involved in the pathogenesis of 
BEM.  
Thirdly, a rupture of the cyst wall has been suggested as a possible trigger of BEM (Jensen et 
al., 1986; Gajadhar and Marquardt, 1992). Three different ways in which cysts can rupture 
have been proposed: (i) Jensen et al. (1986) suggested that some sarcocysts become overdis-
tended during their development, which can cause weakening and rupture of the wall. They 
believe that an increase in the number of bradyzoites, an accumulation of metabolic products 
containing eosinophilic chemo-attractant and cytotoxins, and a passage of fluid into the cyst 
cavity due to enhanced osmotic pressure could cause the distension. Gajadhar and Marquardt 
(1992) assumed that (ii) a genetic defect in the cyst wall and/or (iii) repeated sensitization of 
the host against a certain Sarcocystis species could be a cause of cyst wall rupture.  
Oghiso and Fujiwara already detected an eosinophilic chemotactic factor in BEM lesions in 
1978. The chemotactic activity was correlated with the severity of the lesions, suggesting that 
it was produced locally. They showed that the factor had a protein nature, with a molecular 
weight smaller than bovine albumin. It was heat stable at 60°C, but inactivation occurred after 
trypsin or EDTA treatment. Oghiso and Fujiwara (1978) therefore assumed that the eosino-
philic chemotactic factor consisted of two different active fractions, such as Eosinophil 
Chemotactic Factor of Anaphylaxis (ECF-A) and Eosinophil Stimulation Promoter (ESP). 
Nevertheless, if sarcocysts would possess or induce an eosinophilic chemotactic factor, the 
morbidity of BEM would be much higher, according to Granstrom et al. (1989).  
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2.5 Predisposing factors 
Little is known on the disease profile of BEM, since data in literature are scarce and based on 
small scale studies.  
2.5.1 Animal related factors 
Until now it is assumed that an age predisposition for BEM does not exist. The age of the an-
imals described in literature varies between 15 months and eight years (Imes and Migaki, 
1967). 
Research showed that the prevalence in heifers is statistically higher than in bulls (Reiten et 
al., 1966; Imes and Migaki, 1967). Reiten et al. (1966) could not show a difference in the 
prevalence between cows and heifers, while Imes and Migaki (1967) found that cows were 
less affected with BEM than heifers. In the survey of Reiten et al. (1966) a possible role of 
estrogens in the pathogenesis of BEM is suggested.  
Purebred beef cattle (e.g. Japanese Black, Blonde d’Aquitaine, Hereford, Aberdeen Angus, 
and Shorthorn) as well as crossbreds have been shown to be affected by BEM (Hamilton and 
McCance, 1968; Oghiso and Fujiwara, 1978; Saito et al., 1993; Wouda et al., 2006). Imes and 
Migaki (1967) found in their survey a high percentage of BEM cases in Hereford or Hereford 
cross cattle. Although data in literature show that beef cattle are more often affected, BEM is 
also reported in dairy cattle (Reiten et al., 1966; Imes and Migaki, 1967; Oghiso et al., 1977).  
Finally, Imes and Migaki (1967) reported that carcass finish of bovines condemned for BEM 
was listed good to very good by the farmer. Except for two cases, all had had a health history 
without any evidence of diseases. 
2.5.2 Environmental and farm related factors 
Data in literature suggest that geographical or farm related factors could play a role in BEM. 
Reiten et al. (1966) and Jensen et al. (1986) showed that the condemnation rate for BEM was 
higher in animals fattened in Western USA. Moreover, Wouda et al. (2006) reported cases of 
BEM in one beef cattle herd in the Netherlands with a high incidence (30%) of affected 
slaughtered older females.  
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Seasonally differences are described in literature, but do not show coherent results. Reiten et 
al. (1966) found during each of three years of their study of 173 condemned carcasses a high-
er incidence in animals slaughtered in the summer, suggesting that arthropods would play a 
role. These results however, were not confirmed in the survey by Imes and Migaki (1967) on 
947 affected carcasses during a 14 month survey. They found the highest incidence in autumn 
and in the beginning of the winter, though mentioning that these results could have been in-
fluenced by abnormal weather conditions.  
2.6 Lesions and symptoms 
As described above, BEM is a subclinical myopathy that is not detectable in vivo. It is a 
pathological entity characterized by multifocal or diffuse grey-green discolorations in striated 
muscles (skeletal and cardiac muscle) (Figure 2.1 and Figure 2.2). Lesions are not seen in 
smooth muscles or internal organs. Generally, if only a few lesions are present in the carcass, 
the most active muscles have been shown to be affected, such as the muscles of the tongue, 
the masseter, myocard and diaphragmatic muscle. In severe cases, all striated muscles can be 
affected (Imes and Migaki, 1967). When BEM affected carcasses are exposed to air the color 
of the lesions fades to grey, probably due to oxidative enzymatic changes of myoglobin 
caused by the accumulations of the eosinophilic granulocytes (Hamilton and McCance, 1968; 
Stephan et al., 1998). In some cases lymph nodes can show green areas, due to accumulations 
of eosinophilic granulocytes (Imes and Migaki, 1967; Bundza and Feltmate, 1989).  
The affected carcasses have been subdivided according to the gross pathological findings in 
two types, namely the multiple focal type and the multiple diffuse type (Imes and Migaki, 
1967). Two decades later Jensen et al. (1986) established two other macroscopical categories, 
namely category A and B, with category A being less prevalent. Categories A (Figure 2.1) 
carcasses have few, large focal lesions in striated muscles, whereas category B (Figure 2.2) 
have multiple disseminated lesions in the tongue, oesophagus, heart, diaphragm or skeletal 
muscles.  
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Figure 2.1: BEM, large focal grey green lesions in striated muscles 
 
 
 
Figure 2.2: BEM, multifocal grey-green discolorations in striated muscles (skeletal and cardiac mus-
cle). 
 
Histopathologically (Figure 2.3), the lesions of BEM are characterized by an infiltration of 
eosinophilic granulocytes, lymphocytes, plasma cells, macrophages, multinucleated giant 
cells and mast cells (Imes and Migaki, 1967; Oghiso et al., 1977; Jensen et al., 1986). Most 
studies describe a granulomatous organization of the lesions (Figure 2.4), where the centre 
consists of degenerated muscle fibers and eosinophilic granulocytes (Jensen et al., 1986; Ga-
jadhar et al., 1987; Wouda et al., 2006). Jensen et al. (1986) subdivided these lesions in early, 
intermediate and late stage granulomas and reported that all three stages can occur in the same 
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animal. In those lesions phagocytosis by multinucleated giant cells can be prominent. Exten-
sive fibrosis or an increase of adipose tissue replacing muscle fibers can occur (Jensen et al., 
1986; Oghiso et al., 1977). Vascular alterations are reported in small arteries or arterioles, 
such as oedematous swelling of the intima with cuboidal metaplasia of endothelial cells, de-
generation of the media and cellular infiltration (Oghiso et al., 1977). 
 
 
 
Figure 2.3: Microscopical BEM lesion, remark the infiltration of eosinophilic granulocytes, lympho-
cytes, and macrophages. HE staining, 1000x. 
 
 
Figure 2.4: Microscopical BEM lesion, a granulomatous organization. HE staining, 50x. 
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2.7 Diagnosis and differential diagnosis 
Up till now, in vivo diagnosis of BEM is not possible. A putative diagnosis can be made by 
macroscopical examination at meat inspection. There is the possibility however, to mistake 
BEM lesions with Taeniid cysts (Figure 2.5) having died, due to macroscopical similarities 
between the lesions (Gonzalez et al., 2006). Another differential diagnosis is the migration of 
Hypoderma lineatum, since the larvae can cause gross lesions characterized by foci of yellow-
ish or greenish gelatinous oedema in the diaphragm, pleura, mediastinum and peritoneum 
(Panciera et al., 1993). 
 
 
Figure 2.5: Bovine, skeletal muscle and heart. Both heart and skeletal muscle contain cysticerci 
(Cysticercus bovis). Cysticerci have undergone necrosis and mineralization.  
(Source: http://www.cfsph.iastate.edu) 
 
Definitive diagnosis of BEM in cattle is still based on the histological examination of post-
mortem muscle samples. At this level, BEM lesions can be differentiated from those caused 
by Taeniid cysts and Hypoderma lineatum. Histological examination of Hypoderma lineatum 
lesions reveals oedematous tissue, infiltrated by eosinophilic granulocytes (Panciera et al., 
1993). Although Trichinella spiralis in experimentally infected cattle may produce lesions 
that show microscopically the characteristics of eosinophilic myositis, it is not generally con-
sidered important as a differential diagnosis, because bovines usually do not consume infected 
dead rodents (Bundza and Feltmate, 1989). 
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2.8 Prevention and Treatment 
For the time being, preventive measures and therapeutic treatment are unknown. However, 
since BEM is assumed to be associated with Sarcocystis species, it is realistic to advise the 
preventive measures that are being applied for Sarcocystis species.  
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Bovine Eosinophilic Myositis (BEM) is a pathological entity of unknown etiology and patho-
genesis. Despite the importance of BEM worldwide, resulting from financial losses at the le-
vel of slaughterhouses and meat cutting plants, little information is available on this topic.  
It has been suggested that Sarcocystis species are associated with BEM. This protozoan para-
site is however, present in the muscle tissue (without inducing microscopical lesions) of al-
most 100% of the bovine population, whereas the prevalence of BEM is low. Moreover, the 
information on this parasite in bovines is fragmentary. 
 
The main objective of this thesis is to study the occurrence of bovine Sarcocystis species and 
to improve the understanding of their role in the etiology and pathogenesis of BEM. 
Therefore, the specific sub-objectives are:  
 
1. To develop a reliable molecular technique to identify bovine Sarcocystis species which 
is suitable to be applied both on fresh and formalin fixed/paraffin-embedded tissue in 
order to compare the occurrence of Sarcocystis species in normal cattle and in BEM 
carcasses (Chapter 3). 
2. To determine the occurrence of Sarcocystis species in general and S. hominis in par-
ticular in raw minced meat in Belgium (Chapter 3). 
3. To investigate the role of Sarcocystis species in BEM. 
 Test the hypothesis that BEM might be induced by a specific species of Sarcocystis 
(Chapter 4). 
 Characterize the inflammatory response and the presence of sarcocysts in lesions of 
spontaneous occurring BEM cases by histology and immunohistochemistry (Chap-
ter 5). 
 Investigate the induction of muscular lesions by Sarcocystis antigens after intra-
muscular inoculation (Chapter 5).  
 Compare the lesions of spontaneous occurring BEM cases with lesions induced by 
experimental intramuscular injections with bovine Sarcocystis antigens (Chapter 5). 
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Chapter 3  
Development of a molecular based assay and determina-
tion of the presence of bovine Sarcocystis species in 
minced beef in Belgium 
 
 
Adapted from: 
Vangeel, L., Houf, K., Chiers, K., Vercruysse, J., D’Herde, K., Ducatelle, R., 2007. Molecu-
lar-based identification of Sarcocystis hominis in Belgian minced beef. J. Food Prot. 70, 
1523–1526.  
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3.1 Introduction 
Sarcocystis is a genus of cyst-forming coccidia belonging to the phylum Apicomplexa. This 
genus is composed of more than 200 species (Frenkel and Smith, 2003). They have an obliga-
tory two-host life cycle (Dubey, 1976). In the intermediate host, which can be herbivorous or 
omnivorous, merogony and cyst formation takes place, whereas gamogony and sporogony 
occurs in the carnivorous or omnivorous definitive host (Dubey, 1976; Tenter, 1995).  
Cattle are common intermediate hosts of sarcocysts. The prevalence of Sarcocystis in adult 
bovine muscle is close to 100% in most regions of the world where it has been studied (Bött-
ner et al., 1987; van Knapen et al., 1987; Vercruysse et al., 1989; Fortier et al., 1993; Wolde-
meskel and Gebreab, 1996; Latif et al., 1999; De Bosschere and Ducatelle, 2001; Pena et al., 
2001). 
Bovine muscle can harbor three species, i.e., Sarcocystis cruzi, Sarcocystis hirsuta, and 
Sarcocystis hominis, for which canids, felids, and primates (including humans), respectively, 
are the definitive hosts (Dubey, 1976; Tenter, 1995). Routine identification has been based on 
morphological examination of the cyst wall. S. cruzi, a thin-walled species, can easily be dis-
tinguished from S. hominis and S. hirsuta, both thick-walled sarcocysts, by light microscopy. 
The morphological distinction between S. hominis and S. hirsuta, however, is only possible 
by transmission electron microscopy (TEM) (Dubey et al., 1989; Odening et al., 1995), which 
is cumbersome.   
S. hominis infection in humans is characterized by transient nonspecific gastrointestinal com-
plaints. The clinical course usually is mild and in many cases asymptomatic, although the 
severity is correlated with the number of ingested sarcocysts (Fayer, 2004).  
Because of the difficulties involved in correct identification, little is known about the relative 
distribution of these Sarcocystis species in bovine muscle. From a public health point of view 
accurate data on the prevalence of S. hominis in cattle are needed and should be derived from 
a reliable technique for identification. In some Western European countries, where consump-
tion of raw (minced) bovine meat is common, the occurrence of S. hominis should be moni-
tored.  
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The first objective of the present study was to develop a reliable molecular identification 
technique. The second aim was to use this technique to determine the presence of Sarcocystis 
spp. in general and of S. hominis in particular in raw minced beef in Belgium.  
3.2 Materials and methods 
3.2.1 Development of a molecular based identification technique  
Samples (200 g) of diaphragm of nine slaughtered bovines were examined. The sedimentation 
technique developed by Markus (1979) was used with minor modifications to collect the cysts 
and cyst fragments. A glass funnel closed with a clip near the end of the rubber tube, was 
filled with physiological saline (37°C). A strainer in combination with a single layer of gauze 
was placed on the top of the funnel, and a thin layer of minced meat was put on the gauze and 
remained under the fluid level. This apparatus was then incubated at 37°C for 4 hours without 
stirring. The sediment in the stem of the funnel was drawn through the rubber tube by opening 
the spring clip and collected in a 60 ml screw-cap container (Deltalab, Barcelona, Spain).  
This sediment was examined stereomicroscopically (50x) for the presence of cysts, both thin- 
and thick-walled. Thick-walled cysts were recovered, and each cyst was cut into equal parts 
by microdissection (Figure 3. 1). From each cyst, one half was stored in phosphate-buffered 
solution without Ca2+ and Mg2+ at – 20°C until further analysis by polymerase chain reaction 
(PCR), and the other half of each cyst was processed for TEM because this technique is until 
now accepted as the “gold standard” for identification. 
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Figure 3. 1: Schematic representation of microdissection of thick-walled cysts for further PCR and 
TEM analysis. 
 
 
For cyst lysis prior to DNA extraction, a series of different dilutions and different incubation 
periods of a pepsin/HCl solution were evaluated (Seneviratna et al., 1975; Gajadhar and 
Marquardt, 1992). The effect of 10-fold dilutions of 60 to 0.6 mg pepsin was evaluated every 
ten minutes.   
Thick-walled cyst halves were defrosted at room temperature, and 50 µl of a fresh pepsin/HCl 
solution was added to each sample and incubated at 37°C under optimized conditions (see 
“Results”). Subsequently, DNA was extracted using a commercial genomic DNA purification 
kit (ChargeSwitch® gDNA Micro Tissue Kit, Invitrogen™, Carlsbad CA, USA) according to 
the manufacturer's instructions. 
Sarcocystis genus specific primers were designed based on the 18S rRNA sequence of S. cruzi 
(GenBank accession no. AF017120), S. hominis (AF006470), and S. hirsuta (AF017122), 
which are deposited in the National Center for Biotechnology Information database (Be-
thesda, Md.).  
Optimal PCR conditions were tested by using different concentrations of primers, MgCl2, and 
Taq polymerase. Annealing was performed at different temperatures. 
The specificity of the Sarcocystis genus specific primers was tested by PCR using DNA ex-
tracts of a bovine foetus (7 months of gestation),  Neospora caninum tachyzoites (B. Losson, 
University of Liège, Liège, Belgium), and Toxoplasma gondii tachyzoites (P. Dorny, Institute 
of Tropical Medicine, Antwerp, Belgium). 
The PCR products were size separated by electrophoresis of 2 µl of the reaction products in a 
1% agarose (Invitrogen) gel in 1x Tris-borate-EDTA at 110 V.. 
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The amplicons of the samples were enzymatically purified with ExoSapIt (USB, Cleveland, 
Ohio) and sequenced, using the same primers, with the BigDye®Terminator v3.1 Cycle se-
quencing kit (Applied Biosystems, Lennik, Belgium). The sequencing products were purified 
with the CleanSEQ Dye-terminator removal (Agencourt Bioscience Corporation, Beverly 
Mass.) and run on a 3730 DNA Analyzer (Applied Biosystems). The electrophoregrams were 
exported and converted to the BioEdit v5.06 software package (Tom Hall, Ibis Therapeutics, 
Carlsbad, Calif.). The sequences were aligned to published S. hominis (accession nos. 
AF006470, AF006471, AF006477 and AF176945), S. hirsuta (accession nos. AF017122 and 
AF006469) and S. cruzi (accession nos. AF017120 and AF176935) 18S rRNA sequences ob-
tained from NCBI GenBank by using Pairwise Alignment Algorithms (available from 
http://www.ebi.ac.uk/emboss/align/index.html). 
The half-cysts for TEM were fixed in a solution of 2% glutaraldehyde (Fluka, Buchs, Switzer-
land), and subsequently a solution of 2% glutaraldehyde and 8% bovine serum albumin (BSA 
fraction V, Roche, Mannheim, Germany) was added in order to capture the half-cyst in a pro-
tein coagulate. After 2 hours, the sample was rinsed with sodium-cacodylate trihydrate buffer 
(Fluka) supplemented with 1% calcium chloride dihydrate (Merck, Darmstadt, Germany). 
Then a post fixation procedure was carried out with osmium tetroxide (Serva, Heidelberg, 
Germany) supplemented with Potassium ferricyanide (Merck) overnight. Afterwards a routine 
dehydration and embedding was done.  
 
3.2.2 Detection of Sarcocystis spp. in raw minced beef.  
From January through March 2006, 67 unrelated samples of 200 g raw minced beef were ob-
tained from 25 retail stores. Samples were collected at different times in different retail stores 
and in different areas all over Belgium. The lack of relatedness of the samples was subsequent 
checked through the Belgian tracing system. Raw minced beef is prepared from the muscles 
of the thigh and loin region of cattle.  
The extraction and stereomicroscopic identification of cysts was performed as described 
above. All cysts were collected and counted. Thick-walled cysts were stored individually in 
phosphate-buffered saline without Ca2+ and Mg2+ at -20°C until further analysis. 
Experimental studies - Chapter 3 
 
67 
 
Cyst lysis and DNA extraction were carried out, and the genus specific PCR assay was per-
formed using the optimized conditions (see “Results”), followed by sequence analysis as   
described above.  
 
3.3 Results 
3.3.1 Development of a molecular based identification technique.  
For cyst lysis prior to DNA extraction, the optimal concentration was 60 mg of pepsin 
(Merck, Darmstadt, Germany), 85 mg of NaCl (VWR international, Fontenay-sous-Bois, 
France), and 220 µl of 37% HCl (Merck) diluted in 100 ml distilled water. The optimal incu-
bation time was 30 minutes.  
The primer set SARf (5’-TGGCTAATACATGCGCAAATA-3’) and SARr (5’-
AACTTGAATGATCTATCGCCA-3’) allows detection of the three targeted Sarcocystis spe-
cies. Depending on the species, amplicons of 164 bp for S. hominis, 172 bp for S. cruzi, and 
186 bp for S. hirsuta are generated (Table 3.1). 
 
 
Table 3.1: Localization of primers on the 18S rRNA gene sequences 
species GenBank no. primer SARf 
position 
primer SARr 
position 
amplicon length 
(bp) 
S. cruzi AF017120 152 - 172 303 - 323 172 
S. hirsuta AF017122 163 - 183 328 - 348 186 
S. hominis AF006470 88 - 108 231 - 251 164 
 
 
Optimal PCR reactions were obtained using 4 µl of DNA template, 5 µl of PCR buffer (200 
mM Tris-HCl [pH 8.4] and 500 mM KCl) without Mg2+ (Invitrogen), 2.0 U of Taq poly-
merase (Invitrogen), 1.5 µl of a deoxynucleoside triphosphate mixture containing each de-
oxynucleoside triphosphate (Invitrogen) at a final concentration of 10 mM, 2.3 µl of 50 mM 
MgCl2 (Invitrogen), and 47 pmol of both forward and reverse primers in a total volume of 50 
µl. The optimal conditions for amplification were as follows: initial denaturation at 94°C for 3 
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min, followed by 39 cycles of denaturation at 94°C for 1 min, annealing at 63°C for 1 min, 
elongation at 72 °C for 1 min, and a final elongation at 72°C for 3 min. 
Amplification of the 18S rRNA gene using the SARf and SARr primers produced a fragment 
of the expected size range (150 to 200 bp) in all samples examined. No amplicon was ob-
tained for Toxoplasma gondii, Neospora caninum, and bovine DNA (Figure 3.2).  
 
 
 
 
Figure 3.2: agarose (1%) gel electrophoresis of the amplified products for each species and negative 
controls. Lane 1: molecular size marker, 100 bp DNA ladder; lane 2: S. cruzi; lane 3: S. hominis; lane 
4: S. hirsuta; lane 5: Toxoplasma gondii; lane 6: Neospora caninum; lane 7: Bos taurus; lane 8: nega-
tive control. 
 
 
Sequence analysis of PCR products from five thick-walled half-cysts revealed a similarity of 
96.8% to 100% with sequences deposit in the gene bank for S. hominis (accession nos. 
AF006470, AF006471, AF006477 and AF176945). In contrast, similarities of only 73.5% to 
75.8% and 70.8% to 78.4% were obtained for S. hirsuta (accession nos. AF017122 and 
AF006469) and S. cruzi (accession nos. AF017120 and AF176935), respectively. 
The other cyst halves from three of these five samples were examined by TEM. All three cyst 
walls (Figure 3.3) had finger-like protrusions, which were seated broadly on the cyst surface. 
In the core of the protrusions, long microfilaments were abundant, but no osmiophilic gra-
nules were seen. These findings are in accordance with published descriptions of S. hominis 
(Dubey et al., 1989; Odening et al., 1995). 
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Figure 3.3: Transmission electron micrograph of the cyst wall of a sectioned S. hominis, showing (*) 
the ground substance, () the parasitophorous vacuolar membrane, () microfilaments. 
 
 
3.3.2 Detection of Sarcocystis spp. in raw minced beef  
In 63 (94%) of the 67 samples, complete sarcocysts or fragments of sarcocysts were detected. 
Thick-walled cysts (S. hominis or S. hirsuta) were present in 61 (91%) and thin-walled (S. 
cruzi) were present in 33 (49%) of the samples. Mixed infections of thick- and thin-walled 
cysts were observed in 31 (46%) of the samples (Figure 3.4). 
Amplification of the 18S rRNA gene using the SARf and SARr primers produced an ampli-
con of the expected size range in 60 of the 61 samples examined. From 50 samples, a suffi-
cient amount of the amplicon was obtained for further sequence analysis.  
The result of the sequence analysis of 39 samples was reliable for further species identifica-
tion. The sequences of the amplified fragments from 38 of the 39 PCR products (97.4%) 
showed a similarity of more than 95% to those of S. hominis published in NCBI Genbank 
(accession nos. AF006470, AF006471, AF006477 and AF176945) in contrast to a similarity 
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of 67% to 75% to S. hirsuta and of 72.5% to 79.9% to S. cruzi. The sequence of one sample 
(2.56%) was 97% similar to those from S. hirsuta (accession nos. AF017122 and AF006469), 
77.3% similar to S. hominis, and 70.8% similar to S. cruzi (accession nos. AF017120 and 
AF176935). 
 
 
 
 
Figure 3.4: fragments of thin-walled (thin arrow) and thick-walled (thick arrow) cysts. Bar, 100µm. 
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3.4 Discussion  
To our knowledge, this is the first report using a stereomicroscopical identification technique 
combined with a genomic assay for the identification of bovine sarcocysts. The results from 
the molecular assay were in accordance with those of the TEM examination as all  TEM ex-
amined samples showed finger-like protrusions that were broadly seated on the cyst surface 
and contained no osmiophilic granules, which is consistent with the published descriptions of 
S. hominis (Dubey et al., 1989; Odening et al., 1995). However, S. hirsuta is characterized by 
diagonally bent, bulb- or club-shaped villar protrusions arising with a stalklet from the cyst 
wall and containing large osmiophilic granules (Dubey et al., 1989; Odening et al., 1995). 
Because TEM is laborious, expensive and not readily available, the PCR assay could be the 
method of choice for identification. 
In the present study, sequence analysis of PCR products from cysts collected from minced 
beef in Belgium revealed that S. hominis was present in 97.4% of the samples. This result is in 
contrast with a molecular study conducted in Vermont, USA (Pritt et al., 2006), in which no S. 
hominis was found. However, data about the primers used in the latter PCR assay were not 
described to our knowledge. In two studies based on TEM examination in Brazil (Pena et al., 
2001) and France (Solomon, 1991), S. hominis was detected in 94% and 57% of the samples, 
respectively.  In other studies carried out in India (Jain and Shah, 1987) and Germany (Boch 
et al., 1978) with light microscopic identification, S. hominis prevalences were 12.18% and 
63.3%, respectively. Because Odening et al. (1995) stated that light microscopic examination 
is unreliable for distinguishing S. hominis from S. hirsuta, care should be taken when  com-
paring the latter studies.   
The findings in the present study suggest the existence of a very efficient epidemiological 
cycle of S. hominis. Regarding the prevalence of intestinal sarcocystosis in humans, unfortu-
nately, data in literature on natural infections are limited. In a study carried out in Germany 
(Gauert et al., 1983), 13.64% of patients with intestinal complaints were infected with intesti-
nal parasites, and 2% of these patients were shedding Sarcocystis sporocysts. In two thirds of 
the patients, a connection of intestinal sarcocystosis and clinical symptoms could be made, but 
a distinction between S. hominis and S. suihominis was not made. The reason for limited in-
formation on Sarcocystis prevalence in humans may be explained by the fact that intestinal 
sarcocystosis is characterized by non-specific transient intestinal complaints, as shown in ex-
perimental infection trials (Heydorn, 1977; Pena et al., 2001). Thus, most cases of natural 
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infections may not be reported. However, further research is needed on the prevalence of S. 
hominis in humans to obtain a better insight into the epidemiological cycle of this protozoon.   
In conclusion, this study showed a high occurrence of S. hominis in minced bovine beef at 
retail in Belgium. The genus specific PCR in combination with sequence analysis was a useful 
tool for Sarcocystis identification in bovine muscle. This technique allows a reliable species 
identification and can provide a better insight into the prevalence of S. hominis. This informa-
tion is important from a public health point of view because minced beef is commonly con-
sumed raw in some European countries, including Belgium. 
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4.1 Introduction 
Sarcocystis is a genus of cyst-forming coccidia belonging to the phylum Apicomplexa. They 
have an obligatory two-host life cycle. In the intermediate host the asexual cycle with cyst 
formation takes place, whereas the sexual cycle occurs in the definitive carnivorous host 
(Dubey, 1976).  
Cattle are common intermediate hosts of sarcocysts. The prevalence of Sarcocystis in adult 
bovine muscle is close to 100% in most regions of the world where it has been studied (Böttner 
et al., 1987; van Knapen et al., 1987; Vercruysse et al., 1989; Fortier et al., 1993; Woldemeskel 
and Gebreab, 1996; Latif et al., 1999; De Bosschere and Ducatelle, 2001; Pena et al., 2001; 
Vangeel et al., 2007). Bovine muscle can harbor three species, namely Sarcocystis cruzi with 
canids as definitive hosts, Sarcocystis hirsuta with felids as definitive hosts and Sarcocystis 
hominis with primates as definitive hosts (Heydorn et al., 1975). 
Sarcocystis species have been suggested to play a role in Bovine Eosinophilic Myositis 
(BEM), a specific inflammatory myopathy characterized by multifocal grey-green lesions in 
striated muscle of cattle. Histologically, the lesions consist of an eosinophilic inflammation 
with myofiber degeneration (Imes and Migaki, 1967; Jensen et al., 1986; Oghiso et al., 1977; 
Vangeel et al., 2012). The fact that Sarcocystis species are frequently found in the centre of 
the lesions (Jensen et al., 1986; Gajadhar et al., 1987; Gajadhar and Marquardt, 1992) and the 
evidence that antigens of Sarcocystis species can induce an immune response with predomi-
nantly eosinophilic granulocytes (chapter 5; Vangeel et al., 2012) is an argument in favor of 
their role.  
Bovine Eosinophilic Myositis is hitherto not detectable in the living animal, because affected 
animals appear clinically normal (Imes and Migaki, 1967). It results however in economic 
losses due to carcass condemnation at slaughter as well as meat condemnation in meat cutting 
plants due to abnormal appearance. Worldwide, BEM prevalence reported range from 0.002% 
to 0.028% of slaughtered cattle (Reiten et al., 1966; Imes and Migaki, 1967; Van Hoof et al., 
1972; Bradley and Taylor, 1993; Fortier et al., 1993). Exceptionally high BEM-associated 
carcass condemnations (up to 5%) have been reported in the western part of the USA (Jensen 
et al., 1986).  
Experimental studies - Chapter 4 
 
80 
 
Remarkably, the prevalence of BEM is very low, while the prevalence of sarcocysts in cattle 
is extremely high. The reason for this discrepancy is not clear, but a possible explanation 
could be that BEM may be associated with one specific Sarcocystis species. In the past, Sar-
cocystis identification in BEM lesions has been performed by morphological methods (light 
and transmission electron microscopy). Nevertheless, Odening et al. (1995) stated that light 
microscopic examination is unreliable to distinguish S. hominis from S. hirsuta. Moreover, a 
pitfall of both techniques is the fact that intralesional sarcocysts are mostly damaged (Wouda 
et al., 2006), hindering the identification. Therefore the objective of the present study was to 
determine if BEM is associated with a particular Sarcocystis species using molecular tools.  
 
4.2 Materials and methods 
4.2.1 Sample collection and processing 
From January 1994 through October 2007, striated muscle samples from 97 unrelated bovine 
carcasses (determined by the Belgian meat tracing system), condemned for BEM, were exa-
mined. From each carcass, two to ten muscle tissue samples with lesions and two without le-
sions were collected. Samples were taken from skeletal muscles, diaphragm and, when avail-
able, from the masticatory muscle, tongue, heart and oesophagus. The samples were fixed in 
10% phosphate–buffered formalin for 24 hours and embedded in paraffin. 
 
4.2.2 Histological examination 
Tissue sections were cut at 4 µm and stained with haematoxylin and eosin (HE) for light mi-
croscopic examination. 
The diagnosis of BEM at carcass inspection was confirmed on histology when eosinophilic 
granulocytes were the predominant cell type in the multifocal inflammatory myopathy (Van 
Vleet and Valentine, 2007). 
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The presence of sarcocysts laying inside the lesions (intralesional) as well as sarcocysts laying 
outside a lesion in normal muscle tissue (extralesional) was recorded for each carcass on 
semiserial sections from at random selected samples.  
 
4.2.3 Molecular identification of Sarcocystis spp. at species level  
All paraffin embedded formalin fixed tissues containing intralesional sarcocysts on the HE 
sections were further processed for Laser Capture Microdissection (LCM). Twenty serial sec-
tions from each sample were cut at 5 µm, HE-stained and dehydrated. The protocol by De 
Preter et al. (2003) was used. The intralesional sarcocysts or remnants, and the extralesional 
sarcocysts, if present in the same section, were microdissected using a PixCell II laser capture 
microscope equipped with an infrared diode laser (Arcturus Engineering, Santa Clara, CA, 
USA) as described by Emmert-Buck et al. (1996) and Bonner et al. (1997). Each sarcocyst 
was individually captured on a CapSure™ Macro LCM Cap (Arcturus Bioscience, Mountain 
View, CA, USA). 
DNA from the laser captured sarcocysts was extracted from the LCM caps using the Pico pure 
DNA extraction kit™ (Arcturus Bioscience, Mountain View, CA, USA).  
A fragment of the 18S rRNA gene (164 bp for S. hominis, 172 bp for S. cruzi and 186 bp for 
S. hirsuta) was amplified using the primer set SARf - SARr as described by Vangeel et al. 
(2007). The amplicons of the samples were purified (Qiaquick purification kit, Qiagen GmbH, 
Hilden, Germany) and sequenced using the dideoxy chain terminator method in a 3100 Ge-
netic Analyzer (Applied Biosystems, Lennik, Belgium). The electrophoregrams were expor-
ted and converted to the DNAstar software (DNAstar Inc., Madison, WI, USA). If the identi-
fication of nucleotide positions was not possible due to nearly exactly overlapping peaks in 
the electrophoregrams, the PCR products were purified (Qiaquick purification kit, Qiagen 
GmbH, Hilden, Germany) and cloned into the plasmid pGEM-T Vector System (Promega 
corporation, Madison WI, USA). The sequences of one to six cloned copies per isolate were 
subsequently determined using the dideoxy chain terminator method in a 3100 Genetic Ana-
lyzer (Applied Biosystems, Lennik, Belgium). Sequence analyses and alignments were per-
formed by the DNAstar software (DNAstar Inc., Madison, WI, USA). The sequences were 
aligned to the bovine Sarcocystis species: S. hominis (accession nos. AF006470, AF006471 
and AF176945), S. hirsuta (accession nos. AF017122 and AF006469) and S. cruzi (accession 
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no. AF017120) 18S rRNA gene sequences published in the EMBL GenBank. Multiple align-
ments were made using CLUSTALW (http://www.ebi.ac.uk/clustalw), and phylogenetic 
analysis was carried out using the program Mega v.3.1 (Kumar et al., 2004) by bootstrap test 
of phylogeny (1000 replicates), neighbour-joining and analysing the consensus tree. Bootstrap 
values below 50% were not taken into account. 
4.3 Results 
4.3.1 Histological examination 
In all 97 bovine carcasses the diagnosis of BEM was confirmed by histology. The inflamma-
tory infiltrates in the muscle samples consisted mainly of eosinophilic granulocytes. Addi-
tionally, lymphocytes, plasma cells and macrophages were observed. In the majority of the 
lesions, the inflammation was accompanied by fragmentation of myocytes.  
Intralesional sarcocysts (Figure 4.1) were detected in BEM lesions of 27 (28%) of the 97 bo-
vine carcasses. In six carcasses, more than one sarcocyst was detected inside different BEM 
lesions. In total, 36 intralesional sarcocysts were detected. Fifteen of these 36 intralesional 
cysts were thick-walled (cyst wall: 4.28 ± 0.76 µm thick). The remaining 21 intralesional 
cysts were remnants of which the thickness of the wall could not be determined. All intrale-
sional sarcocysts were damaged (Figure 4.2) and located centrally or paracentrally in the le-
sion. Nine of them were inside a muscle fiber, while 27 were extracellular.  
Extralesional sarcocysts (Figure 4.1) were found in normal muscle tissue of 55 (57%) of the 
97 BEM-carcasses. From those, thin-walled (cyst wall: 1.02 ± 0.18 µm thick) sarcocysts and 
thick-walled (cyst wall: 4.28 ± 0.76 µm thick) sarcocysts were found in 23 and 25 carcasses, 
respectively. A mixed infection (thin- and thick-walled) was found in 7 carcasses. These sar-
cocysts were always intracellular in intact muscle fibers and no inflammation was found sur-
rounding these muscle cells.  
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Figure 4.1: Muscle sample from a BEM carcass, showing a lesion (thin arrow) with a damaged 
intralesional sarcocyst (thick arrow). Remark the extralesional sarcocyst (arrowhead) lying in normal 
muscle tissue without surrounding inflammatory cells. HE-staining, bar = 200 µm. 
 
 
Figure 4.2: Damaged intralesional sarcocyst (thick arrow), lying free and surrounded by degenerated 
eosinophilic granulocytes (thin arrow) and muscle fibers (arrowhead). HE-staining, bar = 50 µm. 
 
 
Experimental studies - Chapter 4 
 
84 
 
4.3.2 Molecular identification of Sarcocystis spp. at species level 
A total of 38 sarcocysts (30 intralesional sarcocysts or remnants thereof, and eight extrale-
sional sarcocysts) were successfully microdissected. After DNA extraction an amplicon of the 
expected size range (150-200 bp), based on the 18S rRNA gene, was generated for 36 (28 
intralesional and eight extralesional) samples. Species identification by sequence analysis of 
the PCR product or the cloned copy was obtained for 27 samples (22 intralesional and five 
extralesional). The results are shown in Table 4.1.  
 
Table 4.1: Molecular identification of intra- and extralesional sarcocysts in Bovine Eosinophilic Myo-
sitis lesions 
 Intralesional sarcocysts  Extralesional sarcocysts 
carcass  species number   species number 
1  S. hominis a 2   S. hominis a 2 
2  S. hominis a 1     
3  S. cruzi d 1     
4  S. hominis a 1     
5  S. hominis a 1     
6  S. hominis a 2     
7  S. hominis a 1     
8  S. hominis a 1     
9  unidentified species e 2   unidentified species e 1 
10  S. hominis b 1   S. hominis b 1 
11  S. hominis a 1     
12  S. hominis a 1     
13  S. hominis a 1     
14  S. hominis a 1     
15  S. hominis a 2     
16  S. hominis a 1   S. hominis a 1 
17  S. hominis a 1     
18  S. hirsuta c 1     
 
a ≥ 98.8% similarity to S. hominis AF176945; b ≥ 98% similarity to S. hominis AF006470; c 97.8% 
similar to S. hirsuta AF006469; d 92.4% similar to S. cruzi AF017120, e ≤ 86.7% similar to one of the 
bovine Sarcocystis species.  
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4.3.2.1 Species identification of intralesional Sarcocystis spp. 
Eighteen intralesional samples (Table 4.1) showed a similarity of more than 98% to S. 
hominis accession number AF176945 or AF006470 (EMBL Genbank) in contrast to less than 
73% similarity to S. hirsuta (accession no. AF006469) and less than 68% to S. cruzi (acces-
sion no. AF017120). The sequence of another sample showed a similarity of 97.8% to S. hir-
suta (accession no. AF006469), 80% to S. hominis (accession no. AF006470) and 74.4% to S. 
cruzi (accession no. AF017120). One sample showed 92.4% similarity to S. cruzi (accession 
no. AF017120), 84.1% to S. hominis (accession no. AF006470) and 82.6% to S. hirsuta (ac-
cession no. AF006469). Two intralesional (Ssp13, Ssp14) samples originating from the same 
carcass (no.9) showed less than 86.7% similarity to a known bovine Sarcocystis species. 
Ssp13 showed 97.7% homology with Ssp14. The amplicons of Ssp13 and Ssp14 had a length 
of 174 and 177 bp, respectively. An alignment report and a phylogenetic tree of their se-
quences with published bovine Sarcocystis spp. are shown in Figure 4.3. The sequence data of 
Ssp13 and Ssp14 reported here have been submitted to EMBL and have been assigned acces-
sion numbers FN394498, FN394499. 
 
4.3.2.2 Species identification of extralesional Sarcocystis spp. 
Four extralesional samples (Table 4.1) showed a similarity of more than 98% to S. hominis 
accession no. AF176945 or  AF006470 (EMBL Genbank) in contrast to less than 74% simi-
larity to S. hirsuta (accession no. AF006469) and less than 69% to S. cruzi (accession no. 
AF017120). One extralesional (Ssp15) sample originating from the same carcass (no.9) as 
Ssp13 and Ssp14 also showed less than 86.7% similarity to a known bovine Sarcocystis spe-
cies (Figure 4.3). Ssp15 showed 99.4% and 97.7% homology with Ssp13 and Ssp14, respec-
tively. The amplicon of Ssp15 had a length of 176 bp. The sequence data of Ssp15 reported 
here have been submitted to EMBL and have been assigned accession number FN394500.  
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4.3.2.3 Pairwise alignment of cloned copies of single sarcocysts 
From fourteen S. hominis samples, sequence analysis of more than one clone per isolate was 
possible. Pairwise alignment of these different cloned copies showed an intra-isolate sequence 
divergence between 0 – 5.5% (homology 94.5 – 100%).  The sequence divergence consisted 
mostly of at random distributed single nucleotide substitutions or insertions. In one of the 
clones of four isolates an insertion of three nucleotides, TAA, located on bp 153-155 (based 
on reference accession no. AF006470) was found.  
Unfortunately, it was not possible to clone the PCR product of the S. cruzi sample into the 
plasmid pGEM-T Vector System or to obtain more than one cloned copy from the Ssp13, 
Ssp14 and Ssp15 samples. 
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Figure 4.3: An alignment report (a) and an unrooted phylogenetic tree (b) are shown. The alignment report is 
generated from a nucleotide fragment of the 18S rRNA gene sequences of the three unidentified Sarcocystis 
species (Ssp13, Ssp14, Ssp15) with published sequences of bovine Sarcocystis species in the EMBL Genbank. S. 
hominis (accession nos. AF006470, AF006471 and AF176945), S. hirsuta (accession nos. AF017122 and 
AF006469) and S. cruzi (accession no. AF017120). Nucleotides that differ from Ssp13, one of the unidentified 
species, are shaded. The forward (SARf) and reverse primer (SARr) are indicated with an arrow. The unrooted 
phylogenetic tree shows the relationship of the different Sarcocystis species. Bootstrap resampling with 1000 
replicates are indicated for the nodes. Lengths of the lines are proportional to the number of base changes. 
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4.4 Discussion 
To our knowledge, this is the first report using microscopic detection combined with a ge-
nomically based assay for the identification of single microdissected sarcocysts in BEM.  
Although sarcocysts or fragmented sarcocysts were present in 28% of the BEM lesions, this 
figure could be an underestimate. As Collins et al. (1980) showed that histological examina-
tion is an insensitive technique for the detection of Sarcocystis. Furthermore, a specific im-
mune response against sarcocysts and subsequent destruction could also result in a decreased 
histological detection. This finding is supported by the fact that muscle cells close to BEM 
lesions expressed MHC class II at their cell membrane (chapter 5; Vangeel et al., 2012) and 
that BEM carcasses contained fewer bradyzoites than normal carcasses (Gajadhar and 
Marquardt, 1992; De Bosschere and Ducatelle, 2001).  
In the present study, we tested the hypothesis that BEM might be associated with a specific 
Sarcocystis species. Literature on this topic is confusing as both thin- and thick-walled sarco-
cysts (Jensen et al., 1986), S. hominis or S. hirsuta (Rimaila-Pärnänen and Nikander, 1980), S. 
cruzi (Gajadhar and Marquardt, 1992), S. hominis (Wouda et al., 2006) or even an unidenti-
fied species (Gajadhar et al., 1987) have been observed in BEM lesions. All studies were 
based on light or transmission electron microscopy for species identification.  The main dis-
advantage of these techniques is that morphological identification can be hampered due to 
damage of the cyst walls which is often present in BEM lesions (Wouda et al., 2006). In the 
present study however, LCM in combination with a PCR based identification technique (Van-
geel et al., 2007) was used to bypass these difficulties. It turned out that different bovine Sar-
cocystis species were present inside BEM lesions, and that the species distribution inside 
these lesions was the same as those in normal bovine muscle. The majority (82%) of 
intralesional sarcocysts were found to be S. hominis, reflecting the high prevalence of this 
species in non-lesional muscles (Vangeel et al., 2007). However, also S. cruzi and S. hirsuta 
were found in lesions of BEM, as well as a hitherto unidentified species.  
Although sequencing of 18S rDNA is being used for species identification of bovine Sarco-
cystis species, difficulties have been described since Fischer and Odening (1998) reported 
considerable differences in sequence between S. hominis isolates. At that moment, they could 
not differentiate if the unclear nucleotide positions were due to sequence variations between 
gene copies within a single sarcocyst, or due to strain variations or mixed infections. In con-
trast, Rosenthal et al. (2008) showed that variation among alleles is rare in S. cruzi 18S rDNA. 
Experimental studies - Chapter 4 
 
89 
 
In the present study, sequence analysis of several cloned copies from single S. hominis cysts 
showed that sequence microheterogeneity (sequence divergence between 0 – 5.5%) exists in 
bovine Sarcocystis spp. as is also described in other Apicomplexan species (Reddy et al., 
1991; Bishop et al., 2000; Caraguel et al., 2007). This is the first time that microheterogeneity 
in Sarcocystis spp. has been demonstrated. This finding may limit the utility of the 18S rRNA 
gene for strain identification in bovine Sarcocystis species.  
In conclusion, our findings indicate that BEM is not associated with one particular Sarcocystis 
species. In addition, the results show that intragenomic variation occurs in S. hominis 18S 
rDNA. Therefore further research of other markers is necessary in order to identify strain 
variations in bovine Sarcocystis spp. which could be associated with BEM. 
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5.1 Introduction 
Bovine Eosinophilic Myositis (BEM) is a rare, specific subclinical myopathy that occurs 
worldwide in clinically healthy cattle (Imes and Migaki, 1967). Although BEM is not detec-
table in the living animal, it results in economic losses due to carcass condemnation at slaugh-
ter as well as meat condemnation in meat cutting plants. It is known to meat inspectors as a 
well-established entity characterized by multifocal or diffuse white to grey-green discolora-
tions in striated muscles. Histologically, BEM essentially consists of myofiber degeneration 
accompanied by an infiltration of large numbers of eosinophilic granulocytes (Imes and Mi-
gaki, 1967; Oghiso et al., 1977; Jensen et al., 1986).  
Reported prevalences of BEM range from 0.002% to 0.028% of slaughtered cattle in different 
parts of the world (Reiten et al., 1966; Imes and Migaki, 1967; Van Hoof et al., 1972; Bradley 
and Taylor, 1993; Fortier et al., 1993). Exceptionally, high BEM-associated carcass condem-
nations (up to 5%) have been reported in the western part of the USA (Jensen et al., 1986).  
The etiology and the pathogenesis of BEM are yet unknown, but in the centre of BEM lesions, 
often damaged Sarcocystis cysts are observed (Jensen et al., 1986; Gajadhar et al., 1987; Ga-
jadhar and Marquardt, 1992; Wouda et al., 2006). Consequently, it has been suggested that 
these cyst-forming protozoa, having an obligatory two-host life cycle, are involved in BEM 
(Gajadhar and Marquardt, 1992; Wouda et al., 2006).  
The involvement of Sarcocystis in BEM is still a matter of debate, since the prevalence of this 
protozoan in normal adult bovine muscle is close to 100% (Vangeel et al., 2007), while BEM 
prevalence is much lower. Moreover, experimental oral inoculation of calves with Sarcocystis 
sporocysts does not lead to BEM (Dubey et al., 1982; Dubey, 1983; Dubey et al., 1988). Ani-
mals presenting BEM, however, carry significantly fewer Sarcocystis bradyzoites in their mus-
cles (Gajadhar and Marquardt, 1992; De Bosschere and Ducatelle, 2001). This may suggest 
that BEM constitutes an immunologic reaction against Sarcocystis antigens. 
The objective of the present study was to investigate if experimental intramuscular inoculation 
of calves with Sarcocystis antigens (lysed sarcocysts) can induce a lesion with the characteris-
tics typical to natural BEM. 
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5.2 Materials and methods 
5.2.1 Natural BEM cases 
5.2.1.1 Sample origin, collection and processing and characterization of the lesions 
Striated muscle samples from 44 unrelated bovine carcasses (determined by the Belgian meat 
tracing system), condemned for BEM, were collected in four Belgian slaughterhouses from 
January 2005 to October 2007. The affected carcasses were from meat type, dairy type as well 
as mixed type animals. Clinical examination of the animals prior to slaughter revealed no 
clinical signs.  
For each carcass, two to ten muscle tissue samples with BEM lesions were taken from skeletal 
muscles, diaphragm and, when available, from the masticatory muscle, tongue, heart and oe-
sophagus. The samples were fixed in 10% phosphate-buffered formalin for 24 hours and em-
bedded in paraffin.  
Tissue sections were cut at 4 µm and stained with haematoxylin and eosin (HE), Giemsa, Von 
Kossa and Von Gieson for light microscopic examination. The lesions were assessed for the 
presence, distribution and organization of the inflammatory cells.  
A panel of monoclonal and polyclonal antibodies, as shown in Table 5.1, directed against 
CD3 (T-cell), CD20 (pan-B cell antigen), MAC387 (Calprotectin, reactive macrophages), 
HLA-DR antigen (MHC class II) and COX-2 (cyclooxygenase-2) were used for immunohis-
tochemical stainings. Staining was performed using the peroxidase streptavidine complex 
(Dakocytomation A/S, Glostrup, Denmark), diaminobenzidine tetrahydrochloride (DAB, 
Sigma-Aldrich, St. Louis, USA) and H2O2 followed by counterstaining with haematoxylin. 
The lesions were assessed for the presence, distribution and organization of the inflammatory 
cells. The diagnosis of BEM at carcass inspection was confirmed by histology when eosino-
philic granulocytes were the predominant cell type in the multifocal inflammatory myopathy 
(Van Vleet and Valentine, 2007). The presence of sarcocysts was examined within the lesions 
as well as in non-affected areas of the same sample. 
Muscle samples from three non-affected bovine carcasses were also included as negative con-
trols for the immunohistochemical stainings. Sample collection in this control group was from 
the same muscles as in the group of the natural BEM cases. 
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Table 5.1: Primary and secondary antibodies used for immunohistochemical labelling of the natural 
BEM lesions and of the experimental injection sites. 
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5.2.2 Experimental intramuscular inoculations with Sarcocystis antigens 
5.2.2.1 Antigen preparations 
The sedimentation technique developed by Markus (1979), with minor modifications (Vangeel 
et al., 2007), was used to collect sarcocysts from fresh samples of 200 g diaphragm from 
slaughtered bovines not presenting any lesions of BEM. The sediment was examined stereomi-
croscopically (magnification 50x) and sarcocysts were recovered using a microclassic unopette 
with capillary pipettes (Brand GMBH, Wertheim, Germany). The cysts were washed three 
times with sterile PBS and 900 sarcocysts were suspended in PBS. The suspension contained a 
mixture of 450 thick- and 450 thin-walled sarcocysts. Soluble antigens were obtained by soni-
cation of the 900 purified sarcocysts on ice using a Vibra-cell VC375 (Sonics and Materials, 
Danbury, CT, USA). Sonication conditions were 375 W, 20 kHz, 20 times for 30 s, pulser on, 
duty cycle: 50%, microtip limit: 4.5. After aliquotation in 6 doses of 450 µl, all antigen prepa-
rations were stored at -20 °C. 
 
5.2.2.2 Animals 
Two clinically healthy male Friesian calves (Bos taurus), aged four months, were used, indi-
cated as calf A and B. They were reared indoors at the Faculty of Veterinary Medicine, Ghent 
University, Belgium and maintained on a ration of hay and concentrates. The animal experi-
ment was approved (EC2007/049) by the Ethical Committee for Animal Experiments of the 
Faculty of Veterinary Medicine, Ghent University, Belgium.  
 
5.2.2.3 Inoculation  
Both calves were inoculated three times with intervals of three weeks with the Sarcocystis 
sonicate (450 µl antigen suspension + 500 µg Quil A). The negative control consisted of 450 
µl PBS admixed with 500 µg Quil A and was injected in the contralateral muscle group. The 
inoculum was each time injected in a different muscle group (both gluteal muscles and both 
sides of the neck muscles) with a 26 Gauge, 1/2 inch needle. Prior to inoculation, the site of 
injection was shaved and marked with a skin marker pen in order to know the exact place for 
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the muscle biopsy. The general symptoms and local response at the injection site were ob-
served for 7 days after inoculation.   
 
5.2.2.4 Sample collection and histopathology of the muscle biopsy at the injection 
site 
An open surgical muscle biopsy specimen (Ledwith and McGowan, 2004) was taken at the 
site of injection one week after each intramuscular inoculation. The sample collection was 
performed under sedation (0.5 ml/ 100 kg Rompun 2%, Bayer, Brussels, Belgium) and local 
anaesthesia of the skin and subcutis (1 ml procain chloridum 4%, Kela, Hoogstraten, Bel-
gium). The specimen (1 cm × 1 cm × 2 cm) was taken surgically with the longitudinal axis 
aligned with the direction of the muscle fibers and placed into 10% neutral buffered formalin 
for 24 hours and thereafter embedded in paraffin.  
Tissue sections were cut at 4 µm and different stainings were performed as described above 
(see 5.2.1.1.).  The muscle biopsies were assessed for the presence, distribution and organiza-
tion of the inflammatory cells.  
5.3 Results 
5.3.1 Natural BEM cases 
Carcass inspection revealed typical macroscopical lesions of BEM (multifocal white to grey-
green discolorations of muscles) in all 44 condemned carcasses. The number and distribution 
of foci in the different skeletal muscle groups, diaphragm, myocardium and the tunica muscu-
laris of the oesophagus varied largely from one carcass to another. A predisposition for a spe-
cific muscle group was not observed. 
Sarcocysts were detected inside BEM lesions (intralesional) of 12 (27.3%) of the 44 examined 
bovine carcasses (Figure 5.1). In six animals, sarcocysts were present in two or more BEM 
lesions. All intralesional sarcocysts were damaged and located centrally or paracentrally in the 
lesion. In non affected muscle areas of the BEM carcasses, sarcocysts were found in intact 
muscle fibers in 31 cases (70.5%).  
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Figure 5.1: Intralesional sarcocyst (thick arrow), lying free and surrounded by degenerated 
eosinophilic granulocytes (thin arrow) and muscle fibers (arrowhead). HE staining. Bar, 50 µm. 
 
 
The inflammatory infiltrates in the affected areas of the muscle samples of the 44 condemned 
bovine carcasses were typical of BEM, and consisted mainly of eosinophilic granulocytes. 
Additionally, lymphocytes, plasma cells and macrophages were observed. Giemsa staining 
showed a moderate infiltration of mast cells which were often partly degranulated. In the ma-
jority of the lesions, the inflammation was accompanied by fragmentation of myocytes. In 
many lesions, the infiltrate of the inflammatory cells was sharply demarcated (focal inflam-
matory organization of the lesion) (Figure 5.2). In other lesions, the infiltrate was scattered 
between muscle fibers (diffuse inflammatory organization of the lesion) and in some cases it 
was accompanied by an increase of collagen bundles (Figure 5.3 and Figure 5.4), as con-
firmed by Von Gieson staining. Some lesions had a central area with necrotic eosinophilic 
granulocytes and degenerated muscle fibers, lined with a rim of epithelioid macrophages sur-
rounded by numerous eosinophilic granulocytes, some lymphocytes and some Langhans’ type 
multinucleated giant cells (granulomatous organization of the lesion) (Figure 5.5). Semiserial 
sections of the lesions did not reveal a different organization of the inflammatory infiltrate. 
Different types of inflammatory organization frequently occurred in the same carcass. 
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Figure 5.2: Focal inflammatory organization of a BEM lesion. Note the predominant infiltration of 
eosinophilic granulocytes. HE staining. Bar, 50 µm. Inset: overview of the lesion. Notice the well 
demarcated accumulation of inflammatory cells. HE staining. Bar, 500 µm. 
 
 
Figure 5.3: Diffuse inflammatory organization of a BEM lesion. The inflammatory cells (mainly 
eosinophilic granulocytes) are distributed between the muscle fibers. HE staining. Bar, 50 µm. Inset: 
overview of the lesion. HE staining. Bar, 250 µm. 
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Figure 5.4: Diffuse inflammatory organization of a BEM lesion with fibrosis. The inflammatory cells 
(mainly eosinophilic granulocytes) are distributed between the muscle cells. Notice the increase of 
fibrous tissue and the atrophy of muscle fibers. HE staining. Bar, 50 µm. Inset: overview of the le-
sion. HE staining. Bar, 250 µm. 
 
 
Figure 5.5: Granulomatous organization of a BEM lesion.  The centre of the lesion consists of  de-
generated eosinophilic granulocytes. This is lined by a rim of epithelioid macrophages surrounded by 
a collar of eosinophilic granulocytes and lymphocytes. HE staining. Bar, 50 µm. Inset: overview of 
the lesion. HE staining. Bar, 250 µm. 
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All BEM lesions contained CD3+ and CD20+ cells. The CD3+ and CD20+ cells were ran-
domly distributed in the lesions, except in lesions with a granulomatous organization, where 
CD20+ cells were organised in a follicular pattern surrounding the rim of epithelioid macro-
phages. MAC387 positive cells were noticed in all types of lesions. In lesions with a focal 
organization, small numbers of MAC387 positive cells were present. In diffuse lesions, these 
MAC387 immunolabelled cells were numerous and randomly scattered inside the lesions. In 
granulomatous lesions, the necrotic centre of the lesion was always MAC387 negative, 
whereas the rim of epithelioid macrophages was positive. The periphery of these lesions was 
strongly infiltrated with MAC387 positive cells. When multinucleated giant cells were pre-
sent, they also showed MAC387 labelling. Expression of MHC class II was demonstrated in 
large numbers of lymphocytes and macrophages as well as in epithelioid macrophages in 
granulomatous lesions. Multinucleated giant cells and eosinophilic granulocytes however, 
were negative. All capillaries and postcapillary venules in and adjacent to the lesion showed 
MHC class II positive endothelium. Some arteriolar endothelium in the lesions expressed 
MHC class II. The endothelium of arteries however, was negative. In almost all tissue sec-
tions of BEM lesions a small number of muscle cells close to the lesion showed a fine granu-
lar cytoplasmic and a plasma membrane MHC class II positive staining (Figure 5.6). COX-2 
expression was detected in endothelial cells from capillaries and arterioles (Figure 5.7) and in 
a small number of macrophages in association with BEM lesions.  
In the three animals of the negative control group, thick-walled sarcocysts were detected in 
one carcass and a mixed infection was found in the second carcass. In the third carcass no 
sarcocysts were observed in the examined histological sections. No inflammation was ob-
served around sarcocysts and immunohistochemical staining for CD3, CD20, MAC387, 
MHCII (HLA-DR) and COX-2 were all negative. 
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Figure 5.6: Note the fine granular cytoplasmic (arrow) and plasma membrane (arrow head) MHC 
class II positive staining of muscle fibers. Bar, 50 µm. 
 
 
Figure 5.7: COX-2 positive immuno-labelling of endothelial cells (arrow) adjacent to the BEM-
lesion. Bar, 50 µm. 
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5.3.2 Experimental intramuscular inoculations with Sarcocystis antigens  
5.3.2.1 Clinical examination 
The injection sites of the negative control inoculum (PBS + adjuvant) in both calves showed 
no alterations.  
Four hours after the first inoculation of the Sarcocystis antigens the general health status of 
both calves was normal. Twenty-four hours later, calf A showed pain reaction upon palpation 
of the injection site with Sarcocystis antigen. After 48 hours, this calf showed a local, well 
circumscribed swelling of 5 mm diameter that was not attached to the skin and not movable. 
The nodular swelling was enlarged by 3 mm the day after and was present until the day of 
biopsy.  
After the second and third inoculation, general and local symptoms were absent in both 
calves.   
  
5.3.2.2 Characterization of the lesion at the injection site 
The muscle biopsy samples collected at the negative control, the first and the second inocula-
tion sites did not show any macroscopically visible alterations. The biopsy samples at the in-
jection site of the third inoculation of both calves showed a slight white discoloration, which 
was not well-circumscribed.  
 Histological and immunohistochemical examination of negative control biopsy samples (PBS 
+ adjuvant) showed no myofiber alterations. Sarcocysts were not found in the histological 
sections. Eosinophilic granulocytes, mast cells and CD20+ cells were not present. Only a few 
CD3+ and MAC387+ cells were observed. MHC class II and COX-2 immunostainings were 
negative. 
Histological examination of the biopsy samples after the first inoculation of Sarcocystis anti-
gen revealed a moderate influx of inflammatory cells (Figure 5.8) the organization of which 
was a diffuse interstitial infiltration in calf B and a focal perimysial localization in calf A. The 
cells were identified as eosinophilic granulocytes (sometimes degranulated),  activated 
macrophages (MAC387+), CD3+ cells (T-lymphocytes) and some CD20+ cells (pan B cell 
antigen). Expression of MHC class II was demonstrated in lymphocytes and macrophages. 
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Giemsa staining showed an infiltration of some mast cells containing metachromatic granules, 
sometimes partly degranulated. In calf A endothelial cells of arterioles were cuboidal and 
showed COX-2 expression. In calf B a mild loss of cross striation of muscle cells was ob-
served.  
 
 
Figure 5.8: Muscle biopsy after the first Sarcocystis antigen inoculation. Note the infiltration of eosi-
nophilic granulocytes (arrow), macrophages and some lymphocytes between the muscle fibers (arrow 
head). HE staining. Bar,  50 µm. 
 
 
Muscle biopsy samples after the second inoculation (Figure 5.9) revealed more severe 
changes. In both calves numerous inflammatory cells: eosinophilic granulocytes, macro-
phages (MAC387+, MHC class II+), multinucleated giant cells with large phagolysosomes, 
CD3+ cells and some CD20+ cells and mast cells were present. Many necrotic myofibers, fi-
brin deposits and focal dystrophic calcification (Von Kossa positive) were observed. Some 
muscle cells showed a row of central nuclei and few muscle fibers showed a fine granular 
cytoplasmic and a plasma membrane MHC class II staining. Endothelial cells showed swollen 
nuclei and cytoplasm and frequently showed MHC class II and COX-2 labelling. 
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Figure 5.9: Muscle biopsy after the second Sarcocystis antigen inoculation. Note the infiltration of 
eosinophilic granulocytes (thin arrows) and the multinucleated giant cells with phagolysosomes (thick 
arrow). HE staining. Bar, 100 µm. 
 
 
The third inoculation revealed profound histopathological alterations (Figure 5.10). There was 
focal necrosis of muscle fibers and inflammatory cells with oedema, surrounded by muscle 
cells with central nuclei containing up to two prominent nucleoli. These altered muscle cells 
frequently showed a fine granular cytoplasmic and a plasma membrane MHC class II+ stain-
ing. Dystrophic calcification was present and inflammatory cells consisted of numerous eosi-
nophilic granulocytes, MAC387+ and MHC class II+ cells, CD3+ and CD20+ cells and few 
mast cells. Vascular changes consisted of an increase in cross sections of capillaries and arte-
rioles. The endothelium was frequently swollen and showed COX-2+ and MHC class II+ stain-
ing.  
In all examined muscle biopsies, from the three antigen inoculations, the inflammatory cells 
showed an at random distribution in the lesions. 
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Figure 5.10: Muscle biopsy after the third Sarcocystis antigen inoculation. Note the necrosis (thin 
arrow) and the extensive inflammatory infiltration (thick arrow) between muscle fibers (arrow head). 
HE staining. Bar,  500 µm. 
5.4 Discussion 
The prevalence of sarcocysts in muscle of non-affected adult cattle, is extremely high (Van-
geel et al., 2007) and no host reaction is observed around these cysts. This suggests that their 
intracellular localization in the muscle probably protects them from the immune system. The 
host cell must therefore not present any parasite antigen on its surface, or else Sarcocystis 
species are able to interfere with antigen presentation actively, as has been suggested for other 
protozoan pathogens (Lüder and Seeber, 2001).  
If sarcocysts are involved in BEM, a possible trigger for the immune response may therefore 
be a rupture of the cyst wall as suggested by Jensen et al. (1986) and Gajadhar and Marquardt 
(1992). In the present study, calves were repeatedly injected intramuscularly with sarcocyst 
antigens to mimic antigen release. This resulted in a muscular lesion at the injection site that 
was histologically similar to the lesions observed in natural BEM cases. Yet already after the 
first injection, microscopical alterations were observed, including the presence of numerous 
eosinophilic granulocytes, inflammatory macrophages, T-lymphocytes, B-lymphocytes, MHC 
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class II expression and induction of COX-2 expression. These lesions aggravated with every 
injection. These results support the hypothesis that antigen release of sarcocysts elicit an im-
mune response and therefore may be involved in the development of BEM. 
In both natural as well as experimentally induced lesions, the results of the immunohisto-
chemical stainings offer some insights in the immune response. The antibody recognizing the 
myelo-monocytic marker MAC387 (calprotectin), suggests that there is continuous, active 
recruitment of blood-derived macrophages in the lesions, because monocytes lose calprotectin 
gradually after migration from blood into tissue (Poston and Hussain, 1993). The inducible 
enzyme, COX-2, can be expressed locally in response to a proinflammatory stimulus (Seibert 
et al., 1994). COX-2 expression in lesion-associated vasculature has been reported in various 
conditions (Koki et al., 2002).  It leads to vasodilatation (Vane and Corin, 2003) and the rein-
forcement of permeability-increasing and chemotactic effects of other mediators (Kumar et 
al., 2005), thus strengthening the inflammation. If antigens are released also the cross striated 
muscle cells can present the antigens to the immune system. Indeed, MHC class II expression 
was found on muscle cells close to the lesion in both natural cases as in the experimentally 
inoculated animals. Nevertheless, it should be stressed that MHC class II antigen presentation 
on muscle cells can only take place when co-stimulatory molecules are present (Wiendl et al., 
2005), the presence of which was not investigated here. Normal muscle cells do not express 
MHC class II, but the induction of the expression on muscle fibers and its role in initiation or 
maintenance of inflammation also has been shown in human inflammatory myopathies 
(Englund et al., 2001).  
In conclusion, we present evidence that antigens of sarcocysts can induce an immune re-
sponse in bovines which is morphologically similar to natural cases of Bovine Eosinophilic 
Myositis. 
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Introduction 
The main objective of this thesis was to study the occurrence of bovine Sarcocystis species 
and their role in Bovine Eosinophilic Myositis (BEM). A better knowledge will provide a 
scientific basis for future control measurements and will help the food safety agencies in their 
decision making regarding this pathology and the impact of S. hominis on public health. In 
this final chapter, the following topics will be discussed in a more general context: 
 
1. Sarcocystis species: food safety and public health perspective 
1.1. Why is monitoring of zoonotic Sarcocystis species recommendable? 
1.2. What is the impact of the confusion in terminology between Sarcosporidiosis and Bo-
vine Eosinophilic Myositis? 
1.3. Is the developed PCR technique applicable for the detection of Sarcocystis in meat in-
spection? 
1.4. How can the differences in occurrence of S. hominis in cattle between countries be ex-
plained? 
1.5. Why are infections of S. hominis in humans rarely reported? 
 
2. Can the current epidemiological cycle explain the high occurrence of S. hominis in 
cattle? 
2.1. Is indirect spread of S. hominis possible due to leaks in hygienic barriers? 
2.2. Does another transmission route exist? 
 
3. Pathogenesis of Bovine Eosinophilic Myositis 
3.1. Do the morphologic findings indicate a unique inflammatory myopathy? 
3.2. What triggers the inflammatory response? 
 
4. General conclusions and further perspectives 
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6.1 Sarcocystis species: food safety and public health perspective 
6.1.1 Why is monitoring of zoonotic Sarcocystis species recommendable? 
From a public health point of view, Sarcocystis can be included in list B within the group 
‘other zoonoses’ of directive 2003/99/EC, which means that they have to be monitored de-
pending on the epidemiological situation in the member states. Regulation 854/2004/EC clas-
sifies Sarcocystis species however under the general term of ‘zoonotic species’ according to 
Taylor et al. (2010). There are to our knowledge, no reliable data on the prevalence of S. 
hominis in man and no data about the relevance for public health. Though data in literature 
show that infection with S. hominis in man is usually mild or asymptomatic (Fayer, 2004) a 
risk analysis study is needed to assess the impact of a zoonotic species for public health. 
EFSA concluded, based on their risk assessment (with the criteria from the Regulation 
178/2002/EC) that the monitoring and clarification of the impact on public health of S. 
suihominis is prioritized over S. hominis (Taylor et al., 2010). In 2008 however, Fosse et al. 
showed that S. suihominis has a low risk for public health, using a quantitative approach for a 
comparative risk assessment in pig slaughter. Nevertheless, these authors mentioned that 
some clinical data for S. suihominis were lacking. As long as these gaps in the knowledge of 
zoonotic Sarcocystis species exist, it is difficult to determine the real impact of S. hominis and 
S. suihominis on public health.  
From an economic point of view, the presence of S. hominis in meat affects the import and 
export of meat. Moré et al. (2011) already mentioned the rejection of beef from Brazil and 
Argentina due to Sarcocystis spp. infection. Moreover, during the present study, our assis-
tance was asked in the diagnosis of Sarcocystis in beef from Honduras.  Since S. hominis 
causes a (limited) risk for public health, the United States Department of Agriculture (USDA) 
and the Food Safety Inspection Service (FSIS) have forbidden import of Honduran beef due 
the presence of sarcocysts (personal communication Bart N., 2009). This is surprising, since 
Dubey et al. (1989) stated that the overall prevalence of Sarcocystis species in US is close to 
100%. Such embargo is made possible by the World Trade Organization, in which a govern-
ment can refuse import of food with a potential public health hazard. This could be a prece-
dent for restricting also export of Belgian beef, given the high occurrence of S. hominis in 
Belgium.  
These reflections emphasize the need for a harmonized and validated method that is interna-
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tionally accepted, for the monitoring of zoonotic Sarcocystis species in cattle, pigs and hu-
mans.  
 
6.1.2 What is the impact of the confusion in terminology between Sarcosporidiosis 
and Bovine Eosinophilic Myositis? 
For a long time, confusion exists between the terminology ‘Sarcosporidiosis’ and ‘Bovine 
Eosinophilic Myositis’ (BEM). ‘Sarcosporidiosis’, used as a synonym for sarcocystosis, is the 
terminology for an infection with Sarcocystis species, causing no inflammatory response in 
muscle tissue. Since most sarcocysts are not macroscopically visible, gross inspection will not 
reveal any pathological changes and without any specific detection technique the sarcocysts 
are not detected in slaughterhouses, though the overall prevalence in cattle is close to 100% 
(Böttner et al., 1987; van Knapen et al., 1987; Vercruysse et al., 1989; Fortier et al., 1993; 
Woldemeskel and Gebreab, 1996; Latif et al., 1999; De Bosschere and Ducatelle, 2001; Pena 
et al., 2001; Vangeel et al., 2007). In rare cases, macroscopical S. hirsuta cysts develop that 
can be detected by visual meat inspection (Dubey et al., 1990). In contrast to Sarcosporidiosis, 
BEM causes typical grey-green lesions. Since the exact etiology is unknown (Dubey et al., 
1989), carcasses and meat that show these lesions have to be declared unfit for human con-
sumption due to pathophysiological changes (regulation 854/2004/EC). For already some 
decades, it has been suggested that Sarcocystis species play a role in this pathology, and  
probably this is the basis for the confusion in terminology. Due to the fact that the term 
Sarcosporidiosis is frequently used instead of BEM, not only problems occur in insurance 
cases, but also data published for sarcocystosis by the European member states in the “The 
Community Report of EFSA on Trends and Sources of Zoonoses, Zoonotic agents, Antimi-
crobial Resistance and Foodborne Outbreaks in the European Union” are not correct. Beside 
Luxembourg, Belgium is however the only European country that submits data about 
sarcocystosis, though the data submitted appear to be the number of carcasses declared unfit 
for human consumption due to BEM. They report a prevalence of Sarcosporidiosis as being 
0.002% in cattle, which represents the prevalence of BEM and not the real occurrence of 
97.4% as was demonstrated in chapter 3 (Vangeel et al., 2007).  
In the future, these terminologies must be used properly in order to report correct data on zo-
onotic Sarcocystis species in the context of the regulation 854/2004/EC and to achieve a clear 
context in insurance cases.  
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6.1.3 Is the developed PCR technique applicable for detection of Sarcocystis in meat 
inspection? 
At the start of this doctoral research, tests used for the detection and identification of bovine 
Sarcocystis species in many diagnostic or research laboratories were based on the morphology 
of sarcocysts by conventional light microscopical or laborious transmission electron 
microscopical techniques (Fortier et al., 1993; Pena et al., 2001). Moreover, researchers ques-
tion the description of Sarcocystis species based on sarcocyst morphology alone, since this 
feature may vary depending on the developmental stage, location of the cyst and the dege-
nerative stage of the parasitized host cell (Tenter et al., 1995). A direct diagnostic test based 
on the detection/identification of parasite specific molecules by molecular based methods 
could provide a valuable alternative in the diagnosis of Sarcocystis infection.  
Therefore, a reliable molecular based identification technique was first developed. In order to 
study the occurrence of bovine Sarcocystis species in beef and in lesions of BEM, the assay 
had to be able to detect sarcocysts on both fresh and formalin fixed/paraffin-embedded sam-
ples. The use of formalin fixed tissue imposes however some restrictions on the primer selec-
tion, as the generation of amplicons of more than 300-400 bp is not successful (Casale et al., 
2010). Nevertheless, a genus specific primerset has been designed, allowing the detection of 
the three known bovine Sarcocystis species and which by sequencing of the amplicon is able 
to identify sarcocysts at species level. The primers did not cross-react with related protozoa 
and the results were in accordance with TEM, still the gold standard at that moment (Vangeel 
et al, 2007). Moreover, the accuracy of the tool was confirmed by exchanging samples with 
Dr. Benjamin Rosenthal (Animal Parasitic Diseases Agricultural Research Service, USDA, 
Beltsville, Maryland, USA) (unpublished data). This laboratory used a different PCR assay 
followed by sequencing (Pritt et al., 2008) using the primers developed by Dubey et al. (2006) 
in the context of genetic characterization of Sarcocystis species in different intermediate 
hosts.  
A disadvantage of our technique is that the PCR generates amplicons with only small diffe-
rences in molecular weights, making differentiation of the three species by routine agarose gel 
electrophoresis impossible. For research purposes, identification is possible by clone- and/or 
sequence analysis of the generated amplicon. In food-safety control however, the latter tech-
niques are expensive and labour intensive, and therefore not routinely implied. 
All molecular techniques developed in the last decade for detection and identification of bo-
vine (and porcine) Sarcocystis species (Gonzalez et al., 2006; Vangeel et al., 2007; Pritt et al., 
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2008) were assessed as unsuitable for ‘high routine inspection’ of zoonotic Sarcocystis spe-
cies by the EFSA’s Scientific Panel (Taylor et al., 2010). An improvement for large scale 
monitoring of Sarcocystis species in cattle could have been the development of a multiplex 
PCR, which we also aimed to develop during this thesis. However, we encountered several 
problems like suboptimal sensitivity in case of co-infections (unpublished data). Another al-
ternative can be the use of a PCR-RFLP technique as described by Yang et al. (2002). Never-
theless, Domenis et al. (2011) have modified our genus PCR, based on the EFSA recommen-
dations, making it more suitable for large scale studies. They labelled the reverse primer with 
a Hex fluorescent dye making it possible to determine the size of the amplicon by capillary 
electrophoresis and thus making sequence analysis for identification of the Sarcocystis species 
redundant.  
 
6.1.4 How can the differences in occurrence of S. hominis in cattle between countries 
be explained? 
Using molecular techniques, the occurrence of S. hominis in bovine meat has recently been 
determined in three different studies. Surprisingly, the occurrence of S. hominis shows large 
variations between the USA and Europe, namely 0% (n=41) in US and Uruguayan samples 
(Pritt et al., 2008) in comparison to 42.7% (n=300) in Italy (Domenis et al., 2011) and 97.4% 
(n=39) in Belgium (Vangeel et al., 2007). Since the extreme high prevalence of S. hominis in 
Belgian beef samples, confirmation of our results using another assay was urged. Our results 
were confirmed by retesting our samples (unpublished data) in the laboratory of Dr. Benjamin 
Rosenthal (Animal Parasitic Diseases Agricultural Research Service, USDA, Beltsville, 
Maryland, USA) with the PCR technique described by Dubey et al. (2006). How can these 
variations than be explained?  
First, these data can reflect real existing differences due to different epidemiological factors 
between countries.  
Secondly, a bias in the occurrence could be caused by differences in the sampling method. 
Both Pritt et al. (2008) and Domenis et al. (2011) sampled a small amount of muscle, 8 mg 
and 25 mg respectively and performed immediately DNA extraction. This may imply two 
risks. The first risk is that, given the low sample volume, there will be no sarcocyst present 
in the sample. This hypothesis could explain why Pritt et al. (2008) had 45.5% samples in 
which no Sarcocystis DNA was detected, while the overall prevalence of Sarcocystis species 
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in US cattle reported is close to 100% (Dubey et al., 1989). This cannot be compared with 
Domenis et al. (2011) since they did not mention the number of negative samples in their sur-
vey. In our study, starting from 200 g beef and including an extra step for cyst collection prior 
to DNA extraction, we did not detect sarcocysts in only 6% of the samples. This indicates that 
our method of sampling is more sensitive. The second risk is that a mixed infection is present 
in a sample, as shown in 46% and 56% of the samples in Belgium and Italy, respectively 
(Vangeel et al., 2007; Domenis et al., 2011). Such co-infections result in overlapping peaks in 
sequence analysis giving uninterpretable results. These samples should than be further ana-
lyzed by cloning and sequencing to identify the different species, which is not performed in 
the study of Pritt et al. (2008). In our study, we have bypassed this problem by extracting 
DNA from individually isolated cysts in each sample. A better alternative is now the method 
of Domenis et al. (2011) where co-infestations can be clearly detected using a fluorescent 
labeled primer for size separation.  
 
6.1.5 Why are infections of S. hominis in humans rarely reported? 
The striking discrepancy between the high occurrence of S. hominis in cattle and the apparent 
low prevalence in humans raises the question: why is S. hominis so little reported in humans? 
One can put forward different hypotheses: 
First, it is possible that the reported prevalence in humans is reliable and that there really 
exists a discrepancy between the prevalence in intermediate and definitive hosts. This could 
be caused by the life cycle of the parasite. Since humans can shed sporocysts during a long 
time and that these sporocysts can survive for a long period in the environment, it is possible 
that one person infects several cattle. The fact that S. hirsuta, as opposed to S. hominis and S. 
cruzi, has a low occurrence in cattle (Vangeel et al., 2007; Domenis et al., 2011) is an argu-
ment against this hypothesis as the patent periods of the three bovine Sarcocystis species are 
similar (Mehlhorn and Heydorn, 1978).  
A second possibility is that data on the prevalence in humans are underreported, due to the 
following factors:  
(i) The majority of infections are asymptomatic, possibly due to a low infection dose. 
However, data in literature on the infection dose are not present. In the study of Pena et al. 
(2001), consumption of 200 g raw meat resulted in gastro-intestinal symptoms in two of six 
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volunteers. Unfortunately, the corresponding number of S. hominis sarcocysts per 200 g was 
not reported. Regarding our study, in 67 samples of 200 g minced beef from retail we have 
found 42 and 25 samples containing respectively 0-10 and 10-30 thick-walled sarcocysts 
(Vangeel et al., unpublished data).  
(ii) Symptomatic infections are difficult to detect, since symptoms of intestinal 
sarcocystosis in humans, if present, frequently occur during the prepatent period (Pena et al 
2001; Fayer, 2004). This implies that faecal shedding of sporocysts is not detectable in stool 
at that moment and consequently most clinical cases will not be linked to intestinal 
sarcocystosis.  
(iii) The sampling frequency of stool is insufficient. Mehlhorn and Heydorn (1978) stated 
that excretion of sporocysts is not constant during the long patent period. This points out that 
routine monitoring of several stool samples over the course of a few days would be needed to 
get better insight in the prevalence.  
(iv) The conventional techniques are probably not sensitive enough and not species speci-
fic. Moreover, the sporocysts are colorless, which makes them difficult to detect (Mehlhorn 
and Heydorn, 1978). Therefore, molecular techniques, as described by Xiang et al. (2009) for 
the detection of Sarcocystis species in stool samples need to be further validated for their sen-
sitivity and optimized for large scale application. 
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6.2 Can the current epidemiological cycle explain the high occurrence of 
S. hominis? 
6.2.1 Is indirect spread of S. hominis possible due to leaks in hygienic barriers? 
The high occurrence of S. hominis in cattle points to a successful epidemiological cycle. As-
suming that the transmission of S. hominis only occurs via ingestion by cattle through food 
and/or water contaminated with human faeces, implies the existence of leaks in hygienic bar-
riers. 
Those supposed gaps in hygienic barriers for S. hominis can (only) be explained by the indi-
rect spread of sporocysts caused by the fact that many sewers are still not connected to a water 
treatment system (causing dissemination of sporocysts during floods) or that farmers still use 
sludge on pastures that are grazed, despite the fact that in Flanders the VLAREM legislation 
prohibits the latter since 2004. In literature these hypotheses have already been put forward, 
but data on the presence of Sarcocystis sporocysts in sludge and surface water are scarce and 
not decisive (Burger and Wilkens, 1986).  
In 2011, Domenis et al. performed a case-control study and found a significant correlation 
between S. hominis positive farms and raw meat consumption by the farmer, absence of se-
wage system and the contamination of pastures with human sewage, suggesting the mainte-
nance of the epidemiological cycle by these factors. In a preliminary study, a questionnaire 
was used to collect information on possible risk factors for S. hominis (Vangeel et al., un-
published data). The results (in Table 6.1) suggest that the majority of the animals were ex-
posed to at least one risk factor. Since we only received information from 26 farmers, these 
data are only indicative. However, four farms had zero-grazing and thus animals were not 
exposed to any of the above mentioned factors. This raises the following question: can S. 
hominis be present in well or drinking water? As this is already described for Toxoplasma, 
Cryptosporidium and Giardia (Betancourt and Rose, 2004; Sroka et al., 2006) further research 
is needed to clarify if Sarcocystis sporocysts are also present in well water and if they can 
pass the water purification system.  
 
 
 
 
General discussion - Chapter 6 
 
125 
 
 
Table 6.1: Preliminary questionnaire-based data from 26 farms on risk factors for indirect transmis-
sion of S. hominis. 
Factor n farms / 26 farms 
Possibility of grazing on pasture 22 
Access to surface water 9 
Regular flooding of pasture 4 
Spreading sludge from sewers on pasture while cleaning  11 
Spreading farm sewage on pasture 21 
Sewers not connected to water treatment system 9 
Common human and farm sewage system  3 
Using sludge from water treatment plants as fertilizer on pastures 0 
 
6.2.2 Does another transmission route exist? 
Data in literature show that ingestion of sporocysts is the major mode for transmission, though 
taking into account the high occurrence of S. hominis, questions arise if other transmission 
routes exist (e.g. mechanical vectors). In 2005, Graczyk et al. reported that synanthropic flies 
can act as mechanical vectors of protozoan parasites. Another possibility could be that blood 
feeding flies transmit merozoites from cow to cow, as an experimental study showed that 
Sarcocystis can be transmitted by blood transfusion (Fayer and Leek, 1979). Moreover, data 
have suggested that hematophagous arthropod species could be vectors for Besnoitia besnoiti 
(a closely related protozoon) explaining the recent spreading of bovine besnoitosis (Alzieu et 
al., 2007; Jacquiet et al., 2010). A preliminary study to test this hypothesis was started in our 
research group (master thesis Tinneke Tuytschaever, 2008). However due to clotting of the 
blood, DNA extraction was not successful, and at this moment further optimalization of the 
DNA extraction is not yet performed.  
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6.3 Pathogenesis of Bovine Eosinophilic Myositis 
6.3.1 Do the morphologic findings indicate a unique inflammatory myopathy? 
Both type I and type IV hypersensitivity have been suggested to play a role in BEM (Jensen et 
al., 1986). The presence of eosinophils which is the most characteristic aspect of this inflam-
matory myopathy is an argument in favor of a type I hypersensitivity. The granulomatous 
organization of lesions in natural BEM, however, suggests that this myopathy may be a type 
IV hypersensitivity (delayed type hypersensitivity, DTH) reaction occurring in the setting of 
chronic antigen stimulation. Meeusen (1999) described three different types of DTH reactions 
in which sensitized T cells recruit macrophages (type I), eosinophilic granulocytes (type II) or 
induce fibrogenic cytokines (type III). The fact that eosinophilic granulocytes are present in 
BEM could thus suggest that it is a DTH type II reaction.  
Based on the data obtained during the different studies, the main argument in favor of a role 
of Sarcocystis in BEM is the fact that intramuscular injection of Sarcocystis antigens in calves 
elicits a similar inflammatory response as the one seen in natural BEM cases. In contrast there 
are still aspects that question the possible role of sarcocysts in these lesions, namely:  
(i) in only 28% of the BEM lesions, intralesional sarcocysts were demonstrated by means of 
histology, 
(ii) in carcasses affected with BEM, intralesional as well as extralesional sarcocysts were pre-
sent in muscle,  
(iii) almost 100% of cattle are infected with Sarcocystis spp., in which no inflammatory re-
sponse is observed, whilst the prevalence of BEM is low,  
(iv) Sarcocystis species are intracellular protozoa, this implies that one would not expect these 
pathogens induce an eosinophilic inflammation, except if these parasites cause an immediate 
(type I) hypersensitivity. However, the fact that the experimentally induced BEM lesions in 
our study (chapter 5; Vangeel et al., 2012) were still present a week after antigen inoculation 
and no neutrophils were seen, may be an argument against immediate hypersensitivity. Since 
eosinophils, neutrophils, lymphocytes and macrophages recruited to the site of mast cell 
degranulation persist for only one to two days (Meeusen, 1999). Meeusen (1999) however 
described that a type I hypersensitivity reaction often occurs concurrently with a DTH type II, 
which can explain that the inflammatory response was still present at the time of muscle biop-
sy, since DTH reactions take two to three days to develop. Bearing in mind, however, that 
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DTH type II reactions are not described in association with protozoa and that Toxoplasma and 
Sarcocystis neurona cause a mononuclear inflammation or a DTH type I reaction 
(Goedegebuure, 1987), neither an immediate hypersensitivity nor DTH type II fits entirely 
within the frame of Sarcocystis playing a role in BEM. Thus BEM is a unique myopathy, un-
less the Th1/Th2 dichotomy does not fit in this pathology. This Th1/Th2 paradigm is first 
described in mice, but data in literature show that cattle do not follow this paradigm (Estes 
and Brown, 2002). Moreover, it has also become clear in mice that many complicated patho-
logical situations cannot be simply explained by the Th1 cell and Th2 cell paradigm (Ouyang 
et al., 2008). Therefore, better understanding of immune responses in BEM is important to 
elucidate the role of sarcocysts. 
6.3.2 What triggers the immune response? 
At this moment, there is no explanation for the discrepancy between the occurrence of BEM 
and the occurrence of Sarcocystis species in cattle. Since sarcocysts are residing in a 
parasitophorous vacuole, just like Toxoplasma, they are expected to be mainly presented on 
MHC class II molecules, since they originate from the extracellular space and are 
intracellularly located within an endocytic vesicle (Lüder and Seeber, 2001). The fact that the 
prevalence of Sarcocystis species in bovine muscle is close to 100% suggests however that 
bovine Sarcocystis species are capable of suppressing the host immune response when present 
in muscle tissue. The development of BEM may after all be detrimental to the survival of the 
parasite. The mechanism of this host-pathogen interaction is not known for bovine sarcocysts, 
but in two related protozoa, Toxoplasma and Sarcocystis neurona, glycosyl-
phosphatidylinositol (GPI)-anchored surface antigens called SnSAGs are described, covering 
the cell surface (Lekutis et al., 2001; Howe et al., 2008). The functional role of these surface 
antigens has not been fully defined, but data suggest that the SAG proteins are involved in 
host cell invasion, immune modulation and/or virulence attenuation (Saeij et al., 2008). Stage 
specific expression has been observed in Toxoplasma gondii, Neospora caninum and 
Sarcocystis neurona (Fernandez-Garcia et al., 2006; Risco-Castillo et al., 2007; Saeij et al., 
2008; Gautam et al., 2011) suggesting that the bradyzoite-specific SAG molecules may be 
important for immune evasion and persistence of a chronic infection (Kim and Boothroyd, 
2005; Saeij et al., 2008). Such mechanisms could also be present in bovine sarcocysts, but 
have not yet been described. 
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The immunohistochemical study in chapter 5 (Vangeel et al., 2012) clearly demonstrates that 
myocytes adjacent to BEM lesions express MHC class II. So, most likely, these muscle cells 
are capable of presenting antigens in BEM. But the question “what exactly triggers antigen 
presentation” in a low number of cattle remains unanswered. Basically, three hypotheses can 
be put forward:  
 the trigger is a parasite related factor through which the immunosuppression disap-
pears and MHC class II, as stated above, is expressed on this specific cell initiating an 
immune response, 
 the trigger is a host related factor through which the primary trigger is host cell  
damage or rupture, causing release of the sarcocyst, 
 the trigger is multifactorial 
 
6.3.2.1 Parasite related factors 
The main hypothesis for a role of parasite related factors in BEM, taking into account that 
extralesional intact sarcocysts are also present in BEM carcasses, is that intralesional 
sarcocysts have lost their capability of suppressing the host immune response. Three different 
mechanisms can be suggested:  
First, it has been described that death of bradyzoites in Sarcocystis and Toxoplasma cysts can 
occur (Dubey et al., 1989; Pavesio et al., 1992). Also in our TEM examination of viable 
sarcocysts, apoptotic bodies were at random detected (Vangeel et al., unpublished data). One 
could suggest that if massive apoptosis occur, the downregulating mechanisms are lost. 
Secondly, it could be that sarcocysts inducing BEM have specific features that interfere with 
the normal host-pathogen interaction, such as a lack of specific surface antigens that are im-
portant for immune evasion, as is already suggested for S. neurona (Howe et al., 2008). If so, 
this will not be a species specific feature since we have demonstrated that all three bovine 
Sarcocystis species can be involved in BEM (chapter 4; Vangeel et al., under review). How-
ever, the involvement of a specific strain is not excluded. Since this would be a disadvanta-
geous feature, one would expect that these strains would disappear, because they will never be 
capable to complete their life cycle or on the other hand it can explain the low prevalence of 
this myopathy.  
Finally, a mutation could arise in the genome of a sarcocyst, through which a modified sur-
face antigen expression arises, causing a change in host-pathogen interaction.  
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6.3.2.2 Host related factors 
The fact that only a small minority of infected animals develop BEM is an argument in favor 
of host related factors. Because studies show that cattle do not follow the Th1/Th2 paradigm 
in the strictest sense, it is suggested that their expression pattern can be impacted by breed or 
genetics, husbandry conditions or health status (Brown et al., 1998; Estes and Brown, 2002).  
Taking into account the data retrieved in a preliminary study on the profiles of 43 bovines 
with BEM (Vangeel et al., unpublished data), one may put forward some reflections:  
First, neither in literature (Imes and Migaki, 1967) nor in our preliminary study one could 
show an age predisposition.  
Secondly, data in literature suggest that meat producing animals are more frequently affected 
with BEM than dairy cattle (Reiten et al., 1966; Oghiso et al., 1977). In our preliminary study, 
the highest affected type was also beef cattle (one Blonde d’Aquitaine and 27 Belgian Blues). 
Nevertheless, this might not reflect a true number, since proportionately more beef cattle are 
slaughtered. Also a breed predilection was not clearly seen, since the BEM carcasses were 
from the following breeds: Belgian Blue, Blonde d’Aquitaine, West-Flemish Red breed, East-
Flemish Red Pied and Holstein Friesian. 
Thirdly, Imes and Migaki (1967) and Reiten et al. (1966) found that heifers, and heifers and 
cows, respectively are more affected than bulls. Also in our preliminary study, 70% of the 
carcasses were of the female sex. The fact that Roberts et al. (2001) described that sex-
associated hormones have an influence on the immune response to protozoan parasites, name-
ly that males develop stronger Th1 and females stronger Th2 responses (e.g. mast cells and 
eosinophils have estrogen receptors), suggests that death/degeneration of sarcocysts could 
result in a strong eosinophil influx, whereas normally a Th1 response would probably clean 
up the parasitized host cell. However, one would then also expect a higher prevalence of 
BEM. Moreover the calves used in our study, in which focal eosinophilic myositis was in-
duced, were males (chapter 5; Vangeel et al., 2012). 
Fourthly, the musculature/muscular development might be a factor involved. During sampling 
of the BEM carcasses, information on the category A-E and the SEUROP classification of the 
carcass was not always available, therefore the mean carcass weight was calculated based on 
the sex. For the male and the female BEM cases the mean carcass weight was 512 kg and 444 
kg, respectively. These are higher than the mean carcass weights in 2007 of slaughtered cattle 
in Flanders (data obtained from Prof. Stefaan De Smet, UGent), namely 478kg for males  
(category A-C) and 371 kg for females (category D and E). Though firm conclusions cannot 
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be drawn, these data suggest that muscle hypertrophy or a rapid weight gain in case of dairy 
cattle could play a role in BEM. This may lead to subclinical muscle injury/damage which 
may result in a release of antigens that are normally hidden from the immune system.  Anoth-
er animal related factor could be genetic diversity in muscle physiology. Not only in humans 
but also in cattle, the calpain system, a family of calcium-dependent intracellular proteases 
and the endogenous inhibitor calpastatin, function as regulators of muscle protein accumula-
tion (Muroya et al., 2012). In humans, tissue specific calpains have been implicated in  dis-
eases like diabetes, LGMD2A and idiopathic eosinophilic myositis (Krahn et al., 2006; Zatz 
and Starling, 2005). In cattle, it has been suggested that this enzyme system plays a role in 
muscle hypertrophy and can be influenced by e.g. β-agonist stimulation (Parr et al., 1992). A 
possible hypothesis is that in animals developing BEM, a genetic defect or an external factor 
exists that causes changes in calpain expression. This in turn, may lead to impaired protein 
turnover and muscle damage, releasing hidden antigens of Sarcocystis. 
 
6.3.2.3 Multifactorial 
Since no conclusive hypotheses for the parasite as well as the host related factors can be put 
forward, one can assume that the trigger for antigen presentation will be a combination of 
different elements.  
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6.4 General conclusions and further perspectives 
During this thesis, particularly in the research area of Sarcocystis, a controversial issue arose, 
namely the high occurrence of S. hominis in minced beef in Belgium. In order to determine 
the exact impact of all zoonotic Sarcocystis species on public health and to further elucidate 
the high occurrence, the variation in prevalence and the modes of transmission, the develop-
ment of a harmonized monitoring program with standardized tools for Sarcocystis species in 
cattle, pigs and man is needed. This would help to implement measures to prevent further cir-
culation of these protozoa.  
Concerning Bovine Eosinophilic Myositis, still many questions remain unanswered. Since the 
prevalence is under 1%, this pathology can be classified as a persisting rare event 
(Saegerman, 2004), of which the detection in vivo will be difficult. By using Sarcocystis 
sonicate for antigen inoculation, it is not clear to which specific antigen(s) the immune re-
sponse is directed. The identification of immunodominant antigens is, however, necessary to 
develop an in vivo diagnostic test. Therefore, a first step is the purification of different anti-
gens of bovine Sarcocystis species to determine immunodominant antigens by Western blot 
analysis. Finally, as the role of sarcocysts in BEM has not yet been fulfilled, also host related 
factors have to be examined. In order to study the mechanisms in BEM, research on the ex-
pression levels of genes involved in this specific myopathy will probably help to further elu-
cidate the pathogenesis. 
 
 
 
 
 
 
 
 
 
 
 
 
General discussion - Chapter 6 
 
132 
 
6.5 References 
Alzieu, J.-P., Cortes, H., Gottstein, B., Jacquiet, P., Dorchies, P., Schelcher, F., L’Hostis, M., 
2007. La besnoitiose bovine: actualités épidémiologiques et diagnostiques. Bull. G.T.V. – 
Hors-série parasitisme des bovins, 41–49. 
 
Betancourt, W.Q., Rose, J.B., 2004. Drinking water treatment processes for removal of Cryp-
tosporidium and Giardia. Vet. Parasitol. 126, 219-34. 
 
Böttner, A., Charleston, W.A.G., Pomroy, W.E., Rommel, M., 1987. The prevalence and 
identity of Sarcocystis in beef cattle in New Zealand. Vet. Parasitol. 24, 157-168. 
 
Brown, W.C., Rice-Ficht, A.C., Estes, D.M., 1998. Bovine type 1 and type 2 responses. Vet 
Immunol. Immunopathol. 63, 45-55. 
 
Burger, H.J., Wilkens, S., 1986. The infection risk of Sarcosporidia in irrigating sewage 
(sludge). In: Epidemiological studies of risks associated with the agricultural use of sewage 
sludge: knowledge and needs. Elsevier, New York, p. 94-97. 
 
Casale, V., Oneda, R., Lavezzi, A.M., Matturri, L., 2010. Optimization of postmortem tissue 
preservation and alternative protocol for serotonin transporter gene polymorphisms amplifica-
tion in SIDS and SIUD cases. Exp. Mol. Pathol. 88, 202-205.  
 
De Bosschere, H., Ducatelle, R., 2001. Inverse correlation between myositis eosinophilica and 
number of Sarcocystis cystozoites in heart tissue of cattle. Vlaams Diergen. Tijdschr. 70, 118–
123. (in Dutch, with English abstract) 
 
Domenis, L., Peletto, S., Sacchi, L., Clementi, E., Genchi, M., Felisari, L., Felisari, C., Mo, 
P., Modesto, P., Zuccon, F., Campanella, C., Maurella, C., Guidetti, C., Acutis, P.L., 2011. 
Detection of a morphogenetically novel Sarcocystis hominis-like in the context of a preva-
lence study in semi-intensively bred cattle in Italy. Parasitol. Res. 109, 1677-87. 
 
General discussion - Chapter 6 
 
133 
 
Dubey, J.P., Speer, C.A., Fayer, R., 1989. Sarcocystosis of animals and man, CRC Press, Bo-
ca Raton, USA, chap.1 and chap.10. 
 
Dubey, J.P., Udtujan, R.M., Cannon, L., Lindsay, D.S., 1990. Condemnation of beef because 
of Sarcocystis hirsuta infection. J. Am. Vet. Med. Assoc. 196, 1095-1096. 
 
Dubey, J.P., Rosenthal, B.M., Morales, J.A., Alfaro, A., 2006. Morphologic and genetic char-
acterization of Sarcocystis sp. from the African grey parrot, Psittacus erithacus, from Costa 
Rica. Acta Parasitologica 51, 161-168. 
 
Estes, D.M., Brown, W.C., 2002. Type 1 and type 2 responses in regulation of Ig isotype ex-
pression in cattle. Vet. Immunol. Immunopathol. 90, 1-10.  
 
Fayer, R., Leek, R.G., 1979. Sarcocystis transmitted by blood transfusion. J. Parasitol. 65, 
890-893. 
 
Fayer, R., 2004. Sarcocystis spp. in human infections. Clin. Microbiol. Rev. 17, 894-902. 
 
Fernández-García, A., Risco-Castillo, V., Zaballos, A., Alvarez-García, G., Ortega-Mora, 
L.M., 2006. Identification and molecular cloning of the Neospora caninum SAG4 gene spe-
cifically expressed at bradyzoite stage. Mol. Biochem. Parasitol. 146, 89-97.  
 
Fortier, G., Collobert, J.F., Viel, S., Mariau, V., 1993. Prevalence of muscular bovine 
sarcocystosis in the Calvados. Rec. Med. Vet. Ec. Alfort 169, 779-781. (In French, with Eng-
lish abstract) 
 
Fosse, J., Seegers, H., Magras, C., 2008. Foodborne zoonoses due to meat: a quantitative ap-
proach for a comparative risk assessment applied to pig slaughtering in Europe. Vet. Res. 
39:01. 
 
Gautam, A., Dubey, J.P., Saville, W.J., Howe, D.K., 2011. The SnSAG merozoite surface 
antigens of Sarcocystis neurona are expressed differentially during the bradyzoite and 
sporozoite life cycle stages. Vet. Parasitol. 183, 37-42. 
General discussion - Chapter 6 
 
134 
 
Goedegebuure, S.A., 1987. Spontaneous primary myopathies in domestic mammals: a review. 
Vet. Q. 9, 155-171.  
 
González, L.M., Villalobos, N., Montero, E., Morales, J., Sanz, R.A., Muro, A., Harrison, 
L.J., Parkhouse, R.M., Gárate, T., 2006. Differential molecular identification of Taeniid spp. 
and Sarcocystis spp. cysts isolated from infected pigs and cattle. Vet. Parasitol. 142, 95-101. 
 
Graczyk, T.K., Knight, R., Tamang, L., 2005. Mechanical transmission of human protozoan 
parasites by insects. Clin. Microbiol. Rev. 18, 128-132. 
 
Howe, D.K., Gaji, R.Y., Marsh, A.E., Patil, B.A., Saville, W.J., Lindsay, D.S., Dubey, J.P., 
Granstrom, D.E., 2008. Strains of Sarcocystis neurona exhibit differences in their surface 
antigens, including the absence of the major surface antigen SnSAG1. Int. J. Parasitol. 38, 
623-631. 
 
Imes, G.D., Migaki, G., 1967. Eosinophilic myositis in cattle - pathology and  
incidence. Proc. Annu. Meet. U. S. Anim. Health. Assoc. 71, 111-122. 
 
Jacquiet, P., Liénard, E., Franc, M., 2010. Bovine besnoitiosis: epidemiological and clinical 
aspects. Vet. Parasitol. 174, 30-36. 
 
Jensen, R., Alexander, A.F., Dahlgren, R.R., Jolley, W.R., Marquardt, W.C., Flack, D.E., 
Bennett, B.W., Cox, M.F., Harris, C.W., Hoffmann, G.A., Troutman, R.S., Hoff, R.L., Jones, 
R.L., Collins, J.K., Hamar, D.W., Cravans, R.L., 1986. Eosinophilic myositis and muscular 
sarcocystosis in the carcasses of slaughtered cattle and lambs. Am. J. Vet. Res. 47, 587-593. 
 
Kim, S.K., Boothroyd, J.C., 2005. Stage-specific expression of surface antigens by Toxoplas-
ma gondii as a mechanism to facilitate parasite persistence. J. Immunol. 174, 8038-8048. 
 
Krahn, M., Lopez de Munain, A., Streichenberger, N., Bernard, R., Pécheux, C., Testard, H., 
Pena-Segura, J.L., Yoldi, E., Cabello, A., Romero, N.B., Poza, J.J., Bouillot-Eimer, S., Ferrer, 
X., Goicoechea, M., Garcia-Bragado, F., Leturcq, F., Urtizberea, J.A., Lévy, N., 2006. 
CAPN3 mutations in patients with idiopathic eosinophilic myositis. Ann. Neurol. 59, 905-
911. 
General discussion - Chapter 6 
 
135 
 
 
Latif, B.M.A., Al-Delemi, J.K., Mohammed, B.S., Al-Bayetti, S.M., Al-Amiry, A.M., 1999. 
Prevalence of Sarcocystis spp. in meat-producing animals in Iraq. Vet. Parasitol. 84, 85-90. 
 
Lekutis, C., Ferguson, D.J., Grigg, M.E., Camps, M., Boothroyd, J.C., 2001. Surface antigens 
of Toxoplasma gondii: variations on a theme. Int. J. Parasitol. 31, 1285-1292. 
 
Lüder, C.K.G., Seeber, F., 2001. Toxoplasma gondii and MHC-restricted antigen presenta-
tion: on degradation, transport and modulation. Int. J. Parasitol. 31, 1355–1369. 
 
Meeusen, E.N., 1999. Immunology of helminth infections, with special reference to immuno-
pathology. Vet. Parasitol. 84, 259-273. 
 
Mehlhorn, H., Heydorn, A.O., 1978. The Sarcosporidia (Protozoa, Sporozoa): life cycle and 
fine structure. Adv. Parasitol. 16, 43-91. 
 
Moré, G., Abrahamovich, P., Jurado, S., Bacigalupe, D., Marin, J.C., Rambeaud, M., 
Venturini, L., Venturini, M.C., 2011. Prevalence of Sarcocystis spp. in Argentinean cattle. 
Vet. Parasitol. 177, 162-165.  
 
Muroya, S., Neath, K.E., Nakajima, I., Oe, M., Shibata, M., Ojima, K., Chikuni, K., 2012. 
Differences in mRNA expression of calpains, calpastatin isoforms and calpain/calpastatin 
ratios among bovine skeletal muscles. Anim. Sci. J. 83, 252-259.  
 
Oghiso, Y., Lee, Y-S., Takahashi, R., Fujiwara, K., 1977. Vascular alterations and degranula-
tion of eosinophil leukocytes in bovine eosinophilic myositis. Nippon Juigaku Zasshi 39, 101-
116. 
 
Ouyang, W., Kolls, J.K., Zheng, Y., 2008. The biological functions of T helper 17 cell effec-
tor cytokines in inflammation. Immunity 28, 454–467. 
 
Parr, T., Bardsley, R.G., Gilmour, R.S., Buttery, P.J., 1992. Changes in calpain and 
calpastatin mRNA induced by beta-adrenergic stimulation of bovine skeletal muscle. Eur. J. 
Biochem. 208, 333-339. 
General discussion - Chapter 6 
 
136 
 
Pavesio, C.E., Chiappino, M.L., Setzer, P.Y., Nichols, B.A., 1992. Toxoplasma gondii: diffe-
rentiation and death of bradyzoites. Parasitol. Res. 78, 1-9. 
 
Pena, H.F. de J., Ogassawara, S., Sinhorini, I.L., 2001. Occurrence of cattle Sarcocystis spe-
cies in raw kibbe from Arabian food establishments in the city of São Paulo, Brazil, and ex-
perimental transmission to humans. J. Parasitol. 87, 1459-1465.  
 
Pritt, B., Trainer, T., Simmons-Arnold, L., Evans, M., Dunams, D., Rosenthal, B.M., 2008. 
Detection of Sarcocystis parasites in retail beef: a regional survey combining histological and 
genetic detection methods. J. Food Prot. 71, 2144-2147. 
 
Reiten, A.C., Jensen, R., Griner, L.A., 1966. Eosinophilic myositis (sarcosporidiosis; sarco) in 
beef cattle. Am. J. Vet. Res. 27, 903-906. 
 
Risco-Castillo, V., Fernández-García, A., Zaballos, A., Aguado-Martínez, A., Hemphill, A., 
Rodríguez-Bertos, A., Alvarez-García, G., Ortega-Mora, L.M., 2007. Molecular characteriza-
tion of BSR4, a novel bradyzoite-specific gene from Neospora caninum. Int. J. Parasitol. 37, 
887-896. 
 
Roberts, C.W., Walker, W., Alexander, J., 2001. Sex-associated hormones and immunity to 
protozoan parasites. Clin. Microbiol. Rev. 14, 476-488. 
 
Saegerman C., 2004. Epidemiosurveillance of rare events in Belgian cattle. PhD thesis, Uni-
versity of Liège.   
 
Saeij, J.P., Arrizabalaga, G., Boothroyd, J.C., 2008. A cluster of four surface antigen genes 
specifically expressed in bradyzoites, SAG2CDXY, plays an important role in Toxoplasma 
gondii persistence. Infect. Immun. 76, 2402-2410. 
 
Sroka, J., Wójcik-Fatla, A., Dutkiewicz, J., 2006. Occurrence of Toxoplasma gondii in water 
from wells located on farms. Ann. Agric. Environ. Med. 13, 169-175. 
 
 
General discussion - Chapter 6 
 
137 
 
Taylor, M.A., Boes, J., Boireau, P., Boué, F., Claes, M., Cook, A.J.C., Dorny, P., Enemark, 
H., van der Giessen, J., Hunt, K.R., Howell, M., Kirjušina, M., Nöckler, K., Pozio, E., Rossi, 
P., Snow, L., Theodoropoulos, G., Vallée, I., Vieira-Pinto, M.M., Zimmer, I-A., 2010. Devel-
opment of harmonized schemes for the monitoring and reporting of Sarcocystis in animals 
and foodstuffs in the European Union. Scientific Report submitted to EFSA. 
 
Tenter, A.M., 1995. Current Research on Sarcocystis species of domestic animals. Int. J. Pa-
rasitol. 25, 1311-1330. 
 
Tuytschaever, T., 2008. Transmissie van Sarcocystis species door Stomoxys calcitrans. Mas-
ter thesis, Faculteit Diergeneeskunde, Universiteit Gent.  
 
Vangeel, L., Houf, K., Chiers, K., Vercruysse, J., D’Herde, K., Ducatelle, R., 2007. Molecu-
lar-based identification of Sarcocystis hominis in Belgian minced beef. J. Food Prot. 70, 1523-
1526.  
 
Vangeel, L., Houf, K., Geldhof, P., Nollet, H., Vercruysse, J., Ducatelle, R., Chiers, K., 2012. 
Intramuscular inoculation of cattle with Sarcocystis antigen results in focal eosinophilic myo-
sitis. Vet. Parasitol. 183, 224-230. 
 
van Knapen, F., Bouwman, D., Greve, E., 1987. Studies on the incidence of Sarcocystis spp. 
in cattle in the Netherlands. Tijdschr. Diergeneeskd. 112, 1095-1100. (in Dutch, with English 
abstract) 
 
Vercruysse, J., Fransen J., van Goubergen, M., 1989. The prevalence and identity of 
Sarcocystis cysts in cattle in Belgium. J. Vet. Med. B Infect. Dis. Vet. Public Health 36, 148-
153. 
 
Woldemeskel, M., Gebreab, F., 1996. Prevalence of sarcocysts in livestock of northwest Ethi-
opia. J. Vet. Med. B Infect. Dis. Vet. Public Health 43, 55-58. 
 
Xiang, Z., Chen, X., Yang, L., He, Y., Jiang, R., Rosenthal, B.M., Luan, P., Attwood, S.W., 
Zuo, Y., Zhang, Y.P., Yang, Z., 2009. Non-invasive methods for identifying oocysts of 
Sarcocystis spp. from definitive hosts. Parasitol. Int. 58, 293-296. 
General discussion - Chapter 6 
 
138 
 
 
Yang, Z.Q., Li, Q.Q., Zuo, Y.X., Chen, X.W., Chen, Y.J., Nie, L., Wei, C.G., Zen, J.S., Att-
wood, S.W., Zhang, X.Z., Zhang, Y.P., 2002. Characterization of Sarcocystis species in do-
mestic animals using a PCR-RFLP analysis of variation in the 18S rRNA gene: a cost-
effective and simple technique for routine species identification. Exp. Parasitol. 102, 212-217. 
 
Zatz, M., Starling, A., 2005. Calpains and disease. N. Engl. J. Med. 352, 2413-2423. 
 
 
 139 
 
 
 
 
 
 
 
 
 
 
 
 
Summary 
 
 
  
 140 
 
 
Summary 
 
141 
 
Cattle are common intermediate hosts of Sarcocystis (S.) species, a genus of heteroxenous 
cyst-forming coccidia belonging to the phylum Apicomplexa. The prevalence of Sarcocystis 
species in adult bovine muscle is close to 100% in most regions of the world. Cattle can har-
bor three species as intermediate host, namely Sarcocystis cruzi, Sarcocystis hirsuta and 
Sarcocystis hominis, with canids, felids and primates (including humans) as definitive hosts, 
respectively. Infection in humans with S. hominis is characterized by transient nonspecific 
gastro-intestinal symptoms. However, the clinical course is usually mild and in many cases 
asymptomatic. 
It has been suggested that Sarcocystis spp. are involved in the development of Bovine 
Eosinophilic Myositis (BEM). This is a specific subclinical myopathy with typical grey-green 
lesions, which occurs worldwide in clinically healthy cattle. Although BEM is not detectable 
in vivo, it results in economic losses due to carcass as well as meat condemnation in slaughter 
and meat cutting plants. Intriguing is the fact that though the prevalence of BEM is low, the 
prevalence of Sarcocystis in cattle is extremely high, and the reason for this discrepancy is 
still not clear.  
 
The first part of the literature review (chapter 1), starts with an overview of bovine Sarcocys-
tis species. The second part (chapter 2) focuses on the present knowledge of BEM. Based on 
both chapters, it is clear that still little or obsolete information is available on bovine Sarco-
cystis species and their role in this multifocal myopathy.  
Therefore the general aim of this doctoral thesis was to assess the occurrence of Sarcocystis 
species in normal bovine muscle, and to contribute to the understanding of their role in BEM.  
 
In the study described in chapter 3, a reliable molecular based identification technique for 
bovine Sarcocystis species was developed. The genus specific PCR based on the 18S rRNA 
gene sequence, followed by sequencing of a specific amplicon, showed to be highly discrimi-
natory. Moreover with this technique, Sarcocystis identification in both fresh and formalin-
fixed/paraffin-embedded bovine muscle was possible.  
Since little was known on the relative distribution of each Sarcocystis species in bovine mus-
cle due to difficulties in correct identification and in view of the zoonotic importance of S. 
hominis, the second aim of the study in chapter 3 was to apply the developed identification 
tool to determine the presence of different Sarcocystis spp. in general and of S. hominis in 
particular in raw minced beef. This study showed a high occurrence of S. hominis (97.4%) in 
minced bovine beef at retail in Belgium. As the consumption of raw minced beef is common 
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in Belgium and in some other European countries, this finding may point to a potential risk 
for public health. Furthermore this finding also suggests the existence of a very efficient epi-
demiological cycle of S. hominis.  
 
To examine the role of Sarcocystis species in BEM, two studies were performed (Chapter 4 
and 5).  
First, Sarcocystis species were identified inside lesions of BEM in order to test the hypothesis 
that BEM might be induced by a specific Sarcocystis species (chapter 4). Therefore, cysts 
present in BEM lesions from 97 condemned carcasses were collected using laser capture 
microdissection. Subsequent, the cysts were identified at species level using the genus PCR 
developed in chapter 3, followed by clone- and/or sequence analysis of the amplicons. 
Intralesional sarcocysts or remnants were found in BEM lesions in 28% of the carcasses. The 
majority (82%) of intralesional Sarcocystis species were identified as S. hominis. However, S. 
cruzi and S. hirsuta, as well as an unidentified species were also present. These observations 
demonstrate that Sarcocystis species present in lesions of BEM are not restricted to a single 
species.  
A second study (chapter 5), assessed whether experimental intramuscular inoculation of Sar-
cocystis antigens can induce similar lesions as those observed in natural cases of BEM. There-
fore, two calves were repeatedly injected intramuscularly with adjuvanted Sarcocystis anti-
gen. The morphological changes at the injection sites in these calves were then histologically 
and immunohistochemically compared to spontaneous lesions from 44 BEM condemned car-
casses sampled in slaughterhouses. Experimental intramuscular injection of Sarcocystis anti-
gen resulted in lesions at the injection sites similar to those of the lesions of spontaneous oc-
curring BEM. They were characterized by massive infiltration of eosinophilic granulocytes, 
reactive macrophages (MAC387+ cells), T-cells (CD3+) and B-cells (CD20+). Both in the ex-
perimental and in the natural cases, COX-2 expression was present in endothelial cells adja-
cent to lesional areas. MHC class II+ staining was found amongst others in muscle cells sur-
rounding the lesion. These findings show that Sarcocystis antigens, when presented to the host 
immune system, can induce an inflammatory response in bovine muscle similar to spontane-
ous occurring BEM. 
 
The doctoral thesis concludes with a general discussion wherein first the results of the diffe-
rent studies are put into a broader context, and secondly the general conclusions and further 
perspectives are presented.  
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In conclusion, evidence is presented that antigens of sarcocysts can induce an immune re-
sponse in bovines resulting in focal eosinophilic myositis. BEM is however not associated 
with one particular Sarcocystis species. Finally, a high occurrence of S. hominis is shown in 
minced bovine beef at retail in Belgium. Therefore, future research should focus on the possi-
ble impact on public health and on the epidemiological cycle of zoonotic Sarcocystis species. 
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Sarcocystis (S.) species zijn heteroxene coccidia en behoren tot het phylum Apicomplexa. Het 
rund treedt op als tussengastheer en kan geïnfecteerd worden door drie species, namelijk Sar-
cocystis cruzi, S. hirsuta en S. hominis, met respectievelijk Canidae, Felidae en primaten 
(waaronder de mens) als eindgastheer. De prevalentie van Sarcocystis species bij runderen is 
in verschillende landen onderzocht en benadert bijna steeds 100%. Een infectie met S. homi-
nis veroorzaakt bij de mens voorbijgaande niet-specifieke gastro-intestinale symptomen. Het 
klinisch verloop is echter meestal mild en in veel gevallen asymptomatisch.  
Het wordt gesuggereerd dat Sarcocystis species een rol spelen in de ontwikkeling van Bovie-
ne Eosinofiele Myositis (BEM). Dit is een subklinische myopathie met typische groengrijze 
letsels die wereldwijd voorkomt in klinisch gezonde runderen. Hoewel BEM niet detecteer-
baar is in vivo, resulteert het zowel op slachthuis- als op uitsnijderijniveau in economische 
verliezen als gevolg van afkeuring door afwijkend uitzicht van het karkas of van het vlees. 
Niettegenstaande de hoge besmettingsgraad van Sarcocystis species in runderen is de preva-
lentie van BEM laag. De reden voor deze discrepantie is tot nu toe niet duidelijk.  
 
In het eerste deel van het literatuuroverzicht worden de verschillende boviene Sarcocystis 
species besproken (hoofdstuk 1). Het tweede deel van het literatuuroverzicht richt zich op de 
huidige kennis van BEM (hoofdstuk 2). Uit beide delen blijkt dat nog steeds weinig of reeds 
verouderde informatie beschikbaar is, zowel over Sarcocystis species in runderen als over hun 
rol in deze multifocale myopathie.  
De algemene doelstelling van deze doctoraatsthesis is dan ook om betere inzichten te verwer-
ven in enerzijds het voorkomen van deze parasiet in normale runderen en anderzijds in hun rol 
in BEM.  
  
De eerste doelstelling van de studie beschreven in hoofdstuk 3, was de ontwikkeling van een 
betrouwbare moleculair gebaseerde identificatie methode voor de drie boviene Sarcocystis 
species. Er werd aangetoond dat identificatie tot op species niveau mogelijk was met de op 
punt gestelde genus specifieke PCR, gebaseerd op het 18S rRNA gen, gevolgd door sequen-
tiebepaling. Daarnaast bleek met deze techniek de identificatie van Sarcocystis spp. in zowel 
verse als formolgefixeerde runderspieren mogelijk. Aangezien tot dan toe, als gevolg van 
identificatie moeilijkheden, weinig gekend was over de relatieve verdeling van de verschil-
lende Sarcocystis species in runderen en omwille van het zoönotisch belang van S. hominis, 
was de tweede doelstelling van hoofdstuk 3 het bepalen van het voorkomen van Sarcocystis 
species in runderen en van S. hominis in het bijzonder in rauw rundsvlees. De resultaten toon-
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den aan dat S. hominis in hoge mate voorkomt (97,4%) in rundsvlees in België. Aangezien de 
consumptie van rauw gehakt rundvlees (bijv. Steak tartaar) veel voorkomt in België en in een 
aantal andere Europese landen, duiden deze bevindingen op een mogelijks onderschat risico 
voor de volksgezondheid. Daarnaast suggereren de resultaten van deze studie dat de epide-
miologische cyclus van S. hominis zeer efficiënt is. 
 
Om de rol van Sarcocystis species in BEM te onderzoeken, werden twee studies uitgevoerd 
(hoofdstuk 4 en 5). 
In een eerste studie (hoofdstuk 4) werd de hypothese, dat BEM veroorzaakt wordt door een 
specifieke Sarcocystis species onderzocht. Sarcocysten aanwezig in BEM letsels van 97 afge-
keurde karkassen werden verzameld door middel van laser capture microdissectie. Vervolgens 
werd species identificatie uitgevoerd met de in hoofdstuk 3 ontwikkelde genus PCR, gevolgd 
door kloonanalyse en/of sequentiebepaling van het amplicon. In 28% van de karkassen met 
BEM letsels werden intralesionale sarcocysten of restanten teruggevonden. De meerderheid 
(82%) van deze intralesionale Sarcocystis species werden als S. hominis geïdentificeerd, hoe-
wel ook S. cruzi, S. hirsuta en een niet gekende Sarcocystis species werden gedetecteerd. 
Hieruit kan worden besloten dat het ontstaan van BEM niet gerelateerd is aan één specifieke 
Sarcocystis species. 
In een tweede studie (hoofdstuk 5) werd nagegaan of experimentele intramusculaire inocula-
tie van kalveren met Sarcocystis antigenen een letsel kan induceren met dezelfde kenmerken 
als BEM. Hiertoe werden twee kalveren herhaaldelijk intramusculair geïnjecteerd met gead-
juveerde Sarcocystis antigenen. De morfologische veranderingen ter hoogte van de injectie-
plaats in deze kalveren werden histologisch en immunohistochemisch onderzocht en vergele-
ken met de BEM letsels van 44 afgekeurde karkassen. Experimentele intramusculaire injectie 
van Sarcocystis antigenen resulteerde in letsels op de injectieplaats die vergelijkbaar waren 
met de letsels van natuurlijk voorkomende BEM. Ze werden gekenmerkt door een massale 
infiltratie van eosinofiele granulocyten, reactieve macrofagen (MAC387+ cellen), T-cellen 
(CD3+) en B-cellen (CD20+). Zowel in de experimentele als in de natuurlijke gevallen werd 
COX-2 expressie waargenomen in endotheelcellen gelegen in de nabijheid van aangetaste 
zones. Daarnaast werd MHC II+ aankleuring vastgesteld in onder andere spiercellen gelegen 
rondom de letsels. Deze resultaten tonen aan dat Sarcocystis antigenen, wanneer zij gepresen-
teerd worden aan het immuunsysteem, een ontstekingsreactie kunnen induceren in de spieren 
van runderen. Bovendien heeft deze inflammatoire respons de kenmerken die ook in BEM 
karkassen worden geobserveerd. 
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Deze doctoraatsthesis besluit met een algemene discussie (hoofdstuk 6) waarin de bevindin-
gen van de verschillende studies in een bredere context worden geplaatst en waarin tenslotte 
de algemene conclusies en verdere perspectieven besproken worden.  
 
Tot besluit kan gesteld worden dat Sarcocystis antigenen in staat zijn om in runderen een im-
muunrespons te induceren die resulteert in focale eosinofiele myositis. Het ontstaan van BEM 
is echter niet geassocieerd met één specifieke Sarcocystis species. Tenslotte werd aangetoond 
dat S. hominis in hoge mate voorkomt in rundsvlees in België. Verder onderzoek naar het mo-
gelijk belang voor de volksgezondheid en naar de epidemiologische cyclus van zoönotische 
Sarcocystis species is daarom aangewezen. 
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